Next Article in Journal
Nasal Administration of Durvillaea antarctica Fucoidan Inhibits Lung Cancer Growth in Mice Through Immune Activation
Previous Article in Journal
Genetic Basis of Non-Syndromic Childhood Glaucoma Associated with Anterior Segment Dysgenesis: A Narrative Review
Previous Article in Special Issue
Therapeutic Potential of Natural Xanthones Against Prostate Adenocarcinoma: A Comprehensive Review of Research Trends During the Last Ten Years (2014–2024)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Echinops as a Source of Bioactive Compounds—A Systematic Review

1
Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria
2
Department of Medical Physics and Biophysics, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2025, 18(9), 1353; https://doi.org/10.3390/ph18091353
Submission received: 9 July 2025 / Revised: 2 September 2025 / Accepted: 5 September 2025 / Published: 9 September 2025
(This article belongs to the Special Issue Natural Products as an Alternative for Treatment of Human Diseases)

Abstract

Background: Echinops is a genus of spiny, herbaceous perennials in the Asteraceae family, known for its distinct morphology and broad pharmacological potential. Both traditional and modern medicinal systems have identified species in this genus as sources of bioactive compounds with anti-inflammatory, antimalarial, antidiabetic, anticancer, and neuroprotective effects. Aims: This study aimed to conduct a systematic literature review and update previous overviews of the recently reported phytochemicals and pharmacological properties of Echinops, systematically summarizing biological activities and their therapeutic applications. Methods: Major electronic medical databases—PubMed, Scopus, Science Direct, Web of Science, and Google Scholar—were systematically searched for publications from 1990 to 2025. Results: A total of 134 studies met our inclusion criteria. Thiophenes and terpenes emerged as characteristic metabolites of the genus, and along with flavonoids and alkaloids, contributed to a wide range of bioactivities. Experimental evidence supports the potential of these compounds as multifunctional agents, although clinical validation remains limited. Conclusions: Echinops is a promising source of structurally diverse metabolites with therapeutic relevance. Further pharmacological and toxicological studies are needed to establish their efficacy and ensure safe medical application.

1. Introduction

The genus Echinops L., popularly referred to as globe thistles, belongs to the Asteraceae family of daisies. With over 120 species, this genus is found worldwide, primarily in the northern hemisphere [1].
The presence of uniflowered capitula aggregated into second-order spherical or oval heads identifies the genus Echinops, which is a member of the Cardueae tribe [2,3]. It is distinct within the tribe because of this trait. Echinops’ great morphological homogeneity makes its taxonomical delimitation virtually uncontested, but it also makes it more difficult to create natural groups and infrageneric classification. The Echinops genus has advantages in both the medical and ecological fields. Potential anti-inflammatory, antibacterial, and analgesic properties of the bioactive chemicals derived from Echinops extracts have been discovered by recent pharmacological investigations. These results suggest the genus’s significance in plant-based drug development [4].

Botanical Identity, Taxonomy, and Cultivation

Based on the geographic distribution of taxa, a variety of Echinops species have been identified in eight geographic regions, including Eastern Europe, Western Europe, Middle Asia, East Asia, Irano-Turanian Region, North Africa, Tropical Africa, and the Arabian Peninsula (Figure 1).
Likely originating from steppe regions of Southeast Europe and West Asia, E. sphaerocephalus is native to temperate parts of Asia and Southern and Eastern Europe [6]. Echinops exaltatus Schrad., Echinops banaticus Rochel ex Schrad., and Echinops ritro L. are three other species that are found in Europe.
There are eight taxa known to exist in Italy. Currently, 12 taxa are known to exist in Greece, while nine are present in Albania [7]. Thirteen taxa are found in Azerbaijan, twelve in Armenia, six in Russia, three in Austria, the Czech Republic, Hungary, and Slovakia, and twenty in Turkey [8,9,10,11,12].
The perennial plant has straight, thorny wooden stems and grows to a height of 30 to 100 cm. The inflorescences are tubular flowers that lead to thorns and are blue and white–silver in color. The leaves are long and have serrated edges without petioles [13]. The genus’s axillary, terminal, compound, single-flowered capitula coalesce into a globose synflorescence. Every capitulum is sessile, supported by tiny, hidden bracts, and disintegrates when it reaches maturity. The capitula are made up of an inner series of imbricate, inflexible, free, or partially joined phyllaries and an outer series of simple or branching extraphyllary white bristles [14,15]. The genus’s corolla may be monomorphic, tubular, glandular, or glabrous and features five lobes that can be white to cream, yellow, pink to red, pale to deep blue, or violet. Florets are tubular and bisexual. The anthers are either violet or purplish. The stigmata are purple or white. Achenes are thickly appressed-pilose and elongated, oblong, or obovate. There are persistent, free, crown-like, or short connate scale-like bristles on the pappus. The single-seeded capitulum is the deciduous unit of dissemination.
More than 120 species of this genus can be found worldwide, particularly in Central Asia, the Mediterranean Basin, and tropical Africa [16]. It grows between 0 and 400 m (0 and 1312 feet) above sea level in areas that are sunny, rocky, or brushy and have more or less mineral-rich soils. The Echinops ritro-globe-thistle species is found across Bulgaria at elevations ranging from 200 to 1500 m. It grows best in rocky and grassy environments [17].
The perennial accessions of Echinops sphaerocephalus, E. exaltatus, and E. banaticus grow in loess soils in Halle/Saale, Germany, in an arid region (104 m above sea level, 51729′ northern latitude, 11759′ eastern longitude, average annual temperature 9.0 7C, rainfall less than 500 L/m2 annually).
E. sphaerocephalus grows best in dry, slightly alkaline soils, suggesting that the plant may be successfully cultivated in areas where other oil plants, such as rapeseed, do not produce abundant harvests. According to descriptions, achene fruits of the Asteraceae family are typically 4–6 mm long.
It can reach a height of 1.5 m and favors calcareous soils. The plant gets its name from the blue or white blossoms that form spherical racemes (3 to 8 cm in diameter) during the July to August blooming season (lat. Echinops—hedgehog, ops—looks). According to [18], seeds have a 25% oil content and ripen in early fall, between September and October. E. sphaerocephalus typically spreads from areas where it was previously artificially planted, but it does so extremely slowly [19].
For optimal development, it requires alkaline, well-drained soils. The majority of Echinops species can tolerate a variety of soil types, including fresh and alkaline soils.
The objective of this systematic review is to comprehensively evaluate the phytochemical constituents and pharmacological activities of Echinops species, and to postulate their potential therapeutic applications based on current preclinical and clinical evidence. Despite the broad pharmacological interest in the genus Echinops, there remains a noticeable lack of detailed phytochemical and pharmacological data. This gap is even more pronounced in the context of Bulgaria, where comprehensive studies on native Echinops species are scarce or fragmented.

2. Materials and Methods

This review aimed to critically evaluate available research on the genus Echinops and systematically organize and present the findings. An attempt was made to include all articles published from 1990 to 2025. Some articles published before 1990 were included based on their significance. Relevant studies were identified using databases such as PubMed, Scopus, ScienceDirect, Web of Science, and Google Scholar. Keyword combinations such as “Echinops,” “nutritional composition,” “phytochemistry,” “pharmacological activity,” “bioactive compounds,” “antioxidant,” “anti-inflammatory,” “traditional medicine,” and “functional foods” were among the search results. Two independent reviewers screened the titles and abstracts of all retrieved records to assess eligibility. Full texts of potentially relevant articles were then evaluated against the inclusion and exclusion criteria. Any disagreements were resolved through discussion or consultation with a third reviewer. No automation tools were used in the selection process. English- and German-language, peer-reviewed journal publications were included. Original research studies and review articles that discussed the pharmacological, chemical, nutritional, botanical, or commercial aspects of Echinops spp. were taken into consideration. When discussing pharmacological effects, studies that were based on in vitro, in vivo, or clinical evaluations were given priority. Articles that were outside of the scope of the review, duplicate entries, or non-peer-reviewed materials were not included. In order to present a systematic review of the current understanding of Echinops spp., with consideration for both traditional and contemporary applications, the chosen research was subjected to critical evaluation and arranged topically.
To conduct this literature search, various databases were utilized, including PubMed, Google Scholar, Springer Nature, Scopus, Medline, ScienceDirect, and Elsevier. The search employed keywords such as anti-Alzheimer, antidiabetic, anti-malarial, antimicrobial, cytotoxicity, Echinops, and phytochemistry (Figure 2). Research articles served as the primary sources for the structures of isolated or synthesized compounds. Our search strategy included recently published accessible data. In addition to global data, our search also included region-specific studies, particularly those focusing on Echinops sphaerocephalus and species native to or studied within Bulgaria. Although several Echinops species have been studied globally, data specifically addressing Echinops sphaerocephalus and the genus as represented in the Bulgarian flora remain limited. This underrepresentation may hinder a full understanding of the species’ potential within regional ethnopharmacology and biodiversity. The primary outcomes sought included pharmacological activities such as antioxidant, anti-inflammatory, antidiabetic, antimalarial, antimicrobial, cytotoxic, and neuroprotective effects. When applicable, data were extracted for all outcome measures reported (e.g., IC50 values, bacterial strains, MIC, biochemical markers, cancer cell lines, clinical efficacy outcomes). Additional data collected included species name, plant part used, geographic origin, type of extract or compound, study design (in vitro, in vivo, or clinical), dose and duration of exposure, and funding sources (when reported). When data were unclear or missing, assumptions were based on standard interpretations of the methodology sections, unless clarified by the authors. Due to the heterogeneity of the included studies, results were synthesized narratively and presented. No quantitative meta-analysis was performed.
This systematic review was conducted following the PRISMA 2020 guidelines.

3. Results and Discussion

The chemical content of Echinops L. has been the subject of many studies. The main constituents of the genus Echinops are terpenes and thiophenes. Flavonoids, phenolic compounds, alkaloids, lipids, and phenylpropanoids have also been reported [20]. The majority of terpenes and flavonoids are extracted from the aerial portion of the plant, while thiophenes are found in the roots. Every morphological section of the plant is said to contain some essential oils, making the genus well known for its essential oil content. It is estimated that over 53 of the identified and isolated compounds have various biological functions. A variety of extracts, essential oils, and chemicals isolated from this genus have been demonstrated to have distinct biological effects, primarily anti-inflammatory, anti-proliferative, and anti-microbial [20].

3.1. Thiophenes

The primary bioactive components of the genus Echinops, thiophenes, are produced biosynthetically from reduced sulfur and fatty acids [21]. The thiophenes are typical constituents and occur in considerable variation. They are characterized by one or three thiophene rings in their structures (Table 1).
The majority of thiophenes have two thiophene rings in their structures, and the majority of thiophenic compounds have an acetylenic functional group. The two most prevalent thiophenes identified from nine species were α-terthiophene and 5-(but-3-en-1-ynyl)-2,2′-bithiophene. Essential oils extracted from the many plants in this genus were shown to contain thiophenes. Thiophenes have been shown to have insecticidal, anti-proliferative, and anti-fungal properties. Most of the biological activities of Echinops L. are due to the presence of thiophenes in their extracts.
Lam et al. used GC-MS to analyze the thiophene content in diethyl ether extracts from roots, leaves, and stems of 16 Echinops species. The authors identified thiophenes only in the roots. Two thiophene dimers, cardopatine and isocardopatine, were found for the first time in E. bannaticus and E. ritro [34].
Liu et al. isolated and structurally elucidated 12 thiophenes from ether and n-butanol extracts of E. grijisii roots [35].
The hexane fraction from the roots of Echinops ellenbeckii O. Hoffm. from Ethiopia was examined by Hymete et al. The fraction yielded seven acetylenic thiophenes, five of which were reported for the first time in this species. The monothiophenes 5-(penta-1,3-diynyl)-2-(but-3-en-1-ynyl)-thiophene, 5-(penta-1,3-diynyl)-2-(4-acetoxy-but-1-ynyl)-thiophene, 5-(penta-1,3-diynyl)-2-(3-hydroxy-4-acetoxybut-1-ynyl)-thiophene, 5-(penta-1,3-diynyl)-2-(3,4-diacetoxy-but-1-ynyl)-thiophene, 5-(penta-1,3-diynyl)-2-(3-chloro-4-acetoxy-but-1-ynyl)-thiophene, 5-(penta-1,3-diynyl)-2-(3,4-epoxy-but-1-ynyl)-thiophene, and the dithiophene 5-[(5-acetoxymethyl-2-thienyl)-2-(but-3-en-1-ynyl)]-thiophene was also isolated [33].
Later, Wand et al. isolated and structurally elucidated four thiophenes from a 95% ethanol extract of E. latifolius roots [42].
Zhang et al. found eight thiophenes, including one new one, echinothiophenegenol, in a 95% ethanol extract of roots of Echinops grijisii Hance (Table 1) [30].
Nakano et al. isolated two polyacetylene thiophenes, echinopsacetylenes A and B, from the roots of Echinops transiliensis (Table 1). Echinopsacetylenes A is the first natural product possessing an R-terthienyl moiety covalently linked with another thiophene moiety. Echinopsacetylenes B is the first natural thiophene conjugated with a fatty acid moiety [40].
Wu et al. isolated a new thiophene, 2,2-Dimethyl-4-[5-(prop-1-ynyl)-2,2-bithiophen-5-yl]-1,3-dioxolane, from ethanol extracts of Echinops spinosissimus subsp. spinosus roots [50].
Li et al. found three new substituted bithiophenes (5′-(3,4-Dihydroxybut-1-yn-1-yl)-[2,2′-bithiophene]-5-carbaldehyde, 4-Hydroxy-1-(5′-methyl-[2,2′-bithiophen]-5-yl)butan-1-one, and 5′-(3,4-Dihydroxybut-1-yn-1-yl)-[2,2′-bithiophene]-5-carboxylic acid, Table 1) in a 95% ethanol extract of the entire Echinops ritro plant, together with twelve known substituted thiophenes, including arctinol b, 4-(5-(penta-1,3-diyn-1-yl)thiophen-2-yl)but-3-yne-1,2-diol, [2,2′-bithiophene]-5-carboxylic acid, 4-([2,2′-bithiophen]-5-yl) but-3-yne-1,2-diol, junipic acid, arctinal, 4-(5′-methyl-[2,2′-bithiophen]-5-yl)but-3-yn-1-ol, 1-([2,2′-bithiophen]-5-yl)ethan-1-one, 4-([2,2′-bithiophen]-5-yl)but-3-yn-1-ol, 1-([2,2′-bithiophen]-5-yl)-4-hydroxybutan-1-one, arctinol A, and arctic acid. The structures were elucidated based on extensive spectroscopic analysis, including 1D, 2D NMR, and MS [37].

3.2. Terpenes

One of the taxa in the Asteraceae family with well-characterized terpenes is the genus Echinops. Sesqui- and triterpenoids have been isolated mainly from the whole plant and aerial parts of the genus Echinops. Lactones are included in the majority of sesquiterpenoids. Sesquiterpene lactones are also the most common secondary metabolites in the Asteraceae family [55,56]. Most triterpenoids occur in a variety of forms, including lactones, esters, sterols, and their glycosides.
The entire plant and aerial portions of the genus Echinops are primary sources of sesqui- and triterpenoids [27,39]. The most common sesquiterpenoid reported is costunolide, which has been isolated from E. amplexicaulis, E. kebericho, and E. pappii [23,24] (Table 2). Abegaz et al. examined the volatile fractions of E. hispidus and E. giganteus and found the sesquiterpene lactone caryophyllene epoxide [23,41,57,58].
Four triterpenoids, namely α-amyrin, α-amyrin acetate, β-sitosterol, and sitosteryl 3-β-glucoside, were isolated from E. ritro [60].
Lupeol and lupeol acetate are common triterpenoids isolated from E. niveus [64], E. giganteus [65], E. integrifolius [66], E. echinatus [67], and E. albicaulis [47].
Phytochemical investigation of the aerial parts of Echinops spinosissimus led to the isolation of nine triterpenoids, including a newly reported natural product 20-oxo-30-nortaraxast-21-en-3β-ol (Table 2) [69].
Hamdan et al. examined the n-hexane fraction of Echinops taeckholmiana Amin and identified four compounds that were isolated from the defatted root extract; these compounds were identified as taraxeryl acetate, β-sitosterol, and stigmasterol-3-β-d-glucoside (Table 2) [61].
Jin et al. later isolated one dimeric sesquiterpene, Latifolanone A, and Atractylenolide (Table 2) in the CH2Cl2-soluble fraction of the MeOH extract of the roots of E. latifolius [44].
Diab et al. recently reported GC–MS analysis of ethanol extract of the E. spinosus from Egypt, identifying 73 primary metabolites, including a monoterpene Z-3,7-dimethyl-2-octene [72].

3.3. Flavonoids

Flavonoids are low molecular weight, bioactive polyphenols that play a vital role in photosynthesis. Flavonoids are secondary metabolites and, as a class of natural compounds, have attracted attention due to their diverse pharmacological activities, particularly their antioxidant properties. Strong antioxidants, such as flavonoids, can shield the body from harmful free radicals. They accomplish this by scavenging free radicals, which is made possible by their capacity to donate hydrogen ions. Flavonoids also possess antifungal, antibacterial, and anti-inflammatory properties; additionally, they can protect the gastrointestinal mucosa from harm caused by necrotic agents and different ulcer models. Furthermore, flavonoids possess anti-carcinogenic properties because they can prevent cancer from developing and spreading by influencing angiogenesis, apoptosis, cellular differentiation, proliferation, and metastasis.
To the best of our knowledge, there is comparatively little research on the flavonol and flavone contents of Echinops species [73,74]. The genus Echinops is in a medium position in the evolutionary advancement of Asteraceae [75], with a flavone/flavonol ratio of 1/1.
The majority of flavonoids in the genus Echinops are flavones, extracted primarily from the entire plant and the members’ aerial portions. Apigenin, the most prevalent flavonoidal aglycone, has been isolated from the flower and entire E. niveus [64], E. echinatus [76], E. integrifolius [66], E. spinosus [77], and E. albicaulis [47] plant (Table 3).
Echinops niveus [64], Echinops echinatus [84], and Echinops giganteus [65] have all been reported to contain luteol (Table 3), while β-sitosterol-3-glucoside and stigmasterol have been isolated from Echinops giganteus [65], Echinops ritro [53], and Echinops transiliensis [41].
A new isoflavone glycoside, echinoside, along with 7-hydroxyisoflavone, kaempferol-4′-methylether, kaempferol-7-methylether, myrecetin-3-O-a-L-rhamnoside, kaempferol, and kaempferol-3-O-a-L-rhamnoside (Table 3), has been isolated from the entire Echinops echinatus plant [74].
Senejoux et al. reported, for the first time, 6-methoxyflavones in Echinops integrifolius, including jaceidin, centaureidin, hispidulin, and axillarin [66].
Trihydroxy methoxy flavone, kaempferol-3-O-methyl ether, and quercetin are the three main flavones in Echinops taeckholmiana Amin; they were first reported by Hamdan [61].

3.4. Alkaloids

Because of their distinct and varied pool of secondary metabolites, including phenolics, sesquiterpene lactones, alkaloids, and triterpenes, plants in the Asteraceae family have been shown to have important therapeutic uses. More than 14 species, including E. echinatus, E. ritro, and E. sphaerocephalus, have been shown to contain simple quinoline alkaloids in their aerial and/or subterranean portions [58,85,86].
Alkaloids isolated from various Echinops spp. were found to be of the quinoline type, primarily 1-methyl-4-quinolone (Echinopsine) [87]. However, research on alkaloids is quite preliminary [88]. Echinopsine, a quinoline alkaloid, is used in traditional Chinese medicine to treat deep-seated breast carbuncles, ulcers, sodoku, and breast milk stoppage. The biological activity of echinopsine is still unclear, despite extensive research on the bioactivity of Echinops sphaerocephalus L. extracts [89]. The echinopsine moiety has the potential for broad-spectrum biological actions, as evidenced by the herbicidal, insecticidal, bactericidal, anti-tumor, antifungal, and antifeedant properties of a range of natural alkaloids containing it [90]. Echinopsine was found to possess activity against tobacco mosaic virus, a single-stranded RNA virus in the family Togaviridae [91]. Chaudhuri found that the aerial sections of E. echinatus contain echinopsine, as well as echinozolinone and echinopsidine, the first alkaloids to be isolated from Echinops spp. [92]. The same plant’s blooms were later used to isolate 7-hydroxyechinozolinone, another alkaloid [85](Figure 3). The alkaloids were in their glycosidic forms. The plants’ aerial portions were the primary source of the alkaloids. The most common alkaloid isolated from four distinct species—E. echinatus, E. nanus, E. albicaulis, and E. orientalis—was echinopsine [80,87,88,92].
A thorough analysis of the volatile components in the roots of E. bannaticus and E. sphaerocephalus led to the identification of 106 and 81 components, respectively, as part of our ongoing efforts to find potentially biologically active chemicals in medicinal plants. Two relatively uncommon chemical families were found in large concentrations in the oils: triquinane sesquiterpenoids (12.7 and 20.9%, respectively) and S-containing polyacetylene compounds (65.5 and 64.1%, respectively). E. bannaticus and E. sphaerocephalus have a strong relationship, and due to their high thiophene polyacetylene chemical concentration, E. grijsii may be included in the Echinops division alongside them. Strong relationships between essential oil constituents were identified using PCA, especially those found in the thiophene polyacetylene and triquinane sesquiterpenoid groups, which are very compatible with the biochemical routes thought to be responsible for the formation of these molecules [58].
According to Horn et al. and Patel et al. (2011), the oil properties of E. sphaerocephalus are comparable to those of other unsaturated plant oils, such as sunflower seed oil, soybean oil, or wheat germ oil [18,93,94]. The ratio of saturated to unsaturated acids and the content of fatty acids are useful markers for assessing the oil’s nutritional and functional worth. Because they are less resistant to rancidity and are more solid at room temperature, high unsaturated fatty acid oils are less common in industrial production, even though they are generally thought to be healthier than saturated fats and help lower blood cholesterol levels.

3.5. Therapeutic Potential of the Genus Echinops

The chemical components and extracts isolated from the many species in this genus have a broad range of biological effects, as summarized in Figure 4.
The Echinops genus has advantages in both the medical and ecological fields. Potential anti-inflammatory, antibacterial, and analgesic properties of the bioactive chemicals derived from Echinops extracts have recently been determined. These results suggest the genus’s significance in plant-based drug development and ethnopharmacology [4].
Based on its chemical composition, Echinops species have long been utilized to cure a variety of illnesses, such as fever, heart and respiratory conditions, bacterial and fungal infections, and more [20]. In China, for example, the roots of Echinops grijisii Hance have been used to clear heat rash, expel miasma, and stimulate milk secretion [30].
In vitro screening and analysis of the phytochemical properties of Echinops spp. have identified antimicrobial, antioxidant, and immunomodulatory therapeutic properties [4].
Antifungal, antibacterial, cytotoxic, antimalarial, and insecticidal pharmacological activities are defined by the presence of thiophenes, while anti-inflammatory, antioxidant, and hepato-protective properties are attributed to terpenes, flavonoids, and other phenolic substances [20,57].

3.5.1. Antioxidant Activity

One of the main pathophysiological mechanisms of many liver illnesses is oxidative stress. Antioxidants from different natural sources have offered clinical promise in the treatment of liver diseases. Oxidative stress can result from liver injury as well as be the cause of hepatocyte damage, malfunction, and cell death. This dichotomy necessitates elucidating the causal relationship through experimental investigations of the hepatotoxic mechanisms of pro-oxidants, such as medications, and particular preventative and therapeutic strategies involving the administration of antioxidants derived from plants. Both the potential hepatoprotective ability of plant extracts in humans and the potential mechanisms of injury should be assessed in experimental models that use several biomarkers to evaluate hepatotoxicity. This strategy improves the likelihood that liver protection seen in animal and cell culture models may be effectively extended to human pathophysiology and treatment.
It has been suggested that the generation of ROS is a precursor to drug-induced hepatotoxicity and a sign of a drug’s potential for hepatotoxicity [85]. Numerous medications have been found to cause oxidative stress, which includes a rise in lipid peroxidation and cellular oxidants, a reduction in the liver’s antioxidant reserves, and a drop in the activity of antioxidant enzymes [37].
In addition to liver disease, oxidative stress is a key pathophysiological process in many other chronic diseases that are relevant to society. In experimental pharmacology, a variety of physiologically active chemicals and secondary metabolites derived from plants, primarily phenolic compounds, are being studied as sources of antioxidants that are essential for preventing disorders linked to oxidative stress. By giving lipids or lipid peroxyl radicals hydrogen atoms, flavonoids have been shown to have the ability to break free radical chains in lipids [95].
The antioxidant activity assessments of Echinops spp. roots are currently insufficient.
Kiyekbayeva et al. evaluated the antioxidant activity of the aqueous methanolic extract of E. albicaulis aerial parts by determining the reactive oxygen species (ROS) levels in active cultures of mononuclear cells from the peripheral blood of healthy adults [47]. The authors found that methanolic extract at concentrations of 50, 10, and 1 mg/mL significantly reduced ROS generation in the active cell cultures (3208, 3242, and 3188 μM H2O2, respectively) compared to the reference compound N-acetylcysteine. Higher concentrations (100, 500, and 1000 mg/mL) of aqueous methanolic extract of E. albicaulis induced overproduction of ROS, which may indicate drug-induced oxidative stress as a mechanism of toxicity [96]. The authors found that at a concentration of 1 mg/mL, the extract significantly (p < 0.001) reduced intracellular ROS production induced by hydrogen peroxide in cell cultures to 6926 μM H2O2, which is more than the reference antioxidant N-acetylcysteine (7378 μM H2O2); at higher concentrations (10 and 50 mg/mL), it showed antioxidant activity (7203.67 and 7768.67 μM H2O2, respectively) comparable to the reference N-acetylcysteine.
Erenler et al. investigated the antioxidant potential of chemical compounds isolated from Echinops orientalis Trauv. [57]. The authors found that seed and leaf extracts have high DPPH and moderate ABTS radical scavenging activities due to the isolated flavones, especially apigenin and its 7-O-glucoside, which exhibit high cation radical scavenging activities.
Quinic acid, a major compound in E. ritro leaves, exerted pronounced dose-dependent antioxidant activity in a cell model of H2O2-induced oxidative stress, restoring MDA levels [97].
3,5- and 4,5-dicaffeoylquinic and chlorogenic acid also have very strong antioxidant effects [98]. Caffeoylquinic acids exhibited a radical scavenging activity similar to that of ascorbic acid. They chelated Fe2+ and Cu2+ and disrupted chain reactions. Chlorogenic acid can scavenge different radicals and protect DNA from damage caused by oxidative stress.
Saida Hanane Zitouni-Nourine et al. recently studied Echinops spinosissimus Turra from Algeria. The authors investigated the total phenolic content and antioxidant properties of the root methanolic extract. The total phenolic content was equal to 95.31 ± 2.90 mg GAE/g DW, while the number of flavonoids was 16.01 ± 0.16 mg CE/g DW. The methanolic extract was found to exhibit antioxidant activity towards the DPPH radical, with an IC50 of 7.99 ± 0.28 mg/mL and a TAC of 30.30 ± 0.54 mg AAE/g DW [54]. Comparatively, previously investigated methanolic extract of E. giganteus root showed an in vitro free radical scavenging effect of 12.54 mg equivalent weight of Trolox per 100 g [99].
Extracts from E. ritro were studied by Zheleva-Dimitrova et al. and were found to effectively restore liver function, reduce oxidative stress, and diminish liver damage.
The presence of flavonoids, phenylethanoid glycosides, and different hydroxybenzoic, hydroxycinnamic, and acylquinic acids in the flowering head and leaf extracts led the authors to conclude that the E. ritro extracts can be employed as antioxidants in medicinal applications and to promote health [53].

3.5.2. Antidiabetic Properties

Numerous variables contribute to type 2 diabetes, a complex metabolic disease. The World Health Organization estimates that this illness affects over 422 million people and results in over 1.6 million fatalities per year. Eight out of every 1000 people are thought to have type 2 diabetes, and as people age, their risk of the disease rises. The number of children and adolescents receiving a diagnosis of this illness has increased in recent years [100]. Plants contain a variety of bioactive phytochemical substances that are thought to have positive health effects (Figure 5) [101,102]. The antidiabetic impact of the methanolic extract of several E. echinatus components has been assessed [88].
The 70% hydro-alcoholic root extract of E. echinatus was reported to have significant antidiabetic activity [103]. Alloxan-induced diabetic rats were investigated. After 21 days of therapy, the rats treated with the extract had lower blood glucose levels (164 mg/dL) compared with the negative control (277.6 mg/dL). Furthermore, the extract demonstrated the capacity to restore normal glomerular and distal convoluted tubule structure in the kidneys, as well as pancreatic islet cell regeneration; additionally, the extract was able to raise high-density lipoprotein levels, while lowering blood cholesterol, serum triglycerides, serum low-density lipoprotein, serum very low-density lipoprotein, and serum alkaline phosphate levels [104].
Aqueous methanolic extract of Echinops echinatus roots had effective hypoglycemic and antihyperglycemic agents in experimental models of type I and type II diabetes. The extract significantly improved glucose tolerance at all time points compared to fructose-fed rats at doses of 100, 300, and 500 mg/kg. The extract also corrected dyslipidemia associated with alloxan-induced diabetes [105].
Total E. spinosus extract and its flavonoid fraction showed promising antidiabetic activity [101]. The authors investigated the antidiabetic properties of both the total extract and its high flavonoid fraction in experimental diabetes induced by streptozotocin injection in rats. Seven days after streptozotocin administration, the diabetic animals were treated daily with total extract, high-flavonoid extract, or metformin as a standard antidiabetic drug for 28 days. The authors found that both total and high-flavonoid extracts demonstrated antidiabetic properties, as evidenced by lower glucose levels and increased levels of insulin, insulin receptor expression rate, and glycogen synthesis. Additionally, both extracts alleviated diabetic complications in the kidneys and liver by decreasing oxidative stress, modulating inflammatory mediators, suppressing the apoptotic cascade, and correcting diabetic dyslipidemia.
K. Benrahou et al. [106] evaluated the antidiabetic enzymatic activity of aqueous and ethanolic extracts of E. Spinosus roots using in vitro and ex vivo assays. The results showed that α-amylase, α-glucosidase, and lipase were effectively inhibited by the macerated ethanolic extract, with IC50 values of 371 ± 0.62, 18.6 ± 1.2, and 10.44 ± 1.08 μg/mL, respectively. The aqueous extract, on the other hand, was less potent against the three enzymes, with IC50 values of 668.8 ± 1.45, 19.68 ± 0.46, and 24.96 ± 1.52 μg/mL, respectively. However, both aqueous and ethanolic extracts significantly lowered blood sugar to 0.96 g/L and 0.93 g/L, respectively, after 90 min.
The terpenoidal components of E. spinosus demonstrate an insulin-like effect and promote intracellular glycogen deposition through the stimulation of glycogen production and inhibition of glycogen phosphorylase. It also improves glycogen metabolism when hepatic glycogen levels are low.
The aqueous extract of E. cephalotes has also been found to possess antidiabetic potential [107]. Another significant family of Echinops metabolites with antidiabetic properties is polysaccharide B, which has been isolated from E. latifolius Tausch. It was found to reduce levels of free fatty acids and triglycerides, improve insulin sensitivity, avoid hepatic metabolic abnormalities, and promote glucose intake and glycogen synthesis in IR-HepG2 cells [87].
Due to the presence of cinnamic acid and its derivatives, Echinops spp. can scavenge free radicals, boost the expression of glucose transporters, regulate or inhibit enzymes involved in glucose metabolism, and restore beta cell function [106].

3.5.3. Anti-Osteoporosis Efficacy of Echinops latifolius

Mongolian medicine Echinops or Echinops latifolius Tausch was found to prevent postmenopausal osteoporosis. An osteoporosis model was established via ovariectomy in rats. Rats were treated with Echinops (16.26, 32.5, or 65 mg/kg/day) for 3 months. Results showed that Echinops significantly increased trabecular interconnectivity, thickness of trabeculae, and the connection of trabeculae. Echinops significantly increased bone mineral density and E2, but significantly reduced ALP and testosterone in dose-dependent manners. The authors concluded that Mongolian Echinops reduced bone loss, delayed the occurrence and development of osteoporosis, and increased ERα, ERβ, p-AKT, and P-ERK in bone marrow-derived stem cells [108].
Later, Wang et al. [89] examined Echinops latifolius Tausch and its influence on the trabecular micro-architecture of ovariectomized rats by interfering with the metabolism of amino acids and glycerophospholipids, as determined by metabolomics profiling (Figure 6).
The authors observed a severe impairment of the bone micro-architecture of ovariectomized rats after administration of Echinops latifolius. In comparison with the control group, the morphologic parameters, including bone surface to bone volume and trabecular separation, increased significantly in ovariectomized rats (p < 0.01), while bone volume fraction, trabecular thickness, and trabecular number decreased significantly.

3.5.4. Alzheimer’s Disease Prevention

Alzheimer’s disease is one of the most prevalent forms of age-related neurodegenerative dementia affecting elderly individuals worldwide. It is estimated that 13% of individuals over 65 and 45% of those over 85 suffer from Alzheimer’s syndrome [90,91].
Acetylcholinesterase (AChE) inhibition is one of the mechanisms through which anti-Alzheimer’s medications work. In one study, extracts from E. ritro were examined for their anti-cholinesterase (AChE and butyrylcholinesterase, BChE) activity (Figure 7).
E. echinatus and E. ritro were found to inhibit AChE, compared to galanthamine and physostigmine as standards [80,92]. Different extracts of leaves, stems, flowers, and achenes of E. echinatus were compared to galanthamine and physostigmine as standards. The methanol and ethyl acetate extracts showed the strongest AChE and BChE inhibitors. Ethyl acetate extracts of stems and leaves, on the other hand, strongly inhibited AChE, with IC50 values of 15.3 and 15.8 μg/mL, compared to physostigmine and galanthamine, which had IC50 values of 0.05 and 2.1 μM/mL, respectively. Moreover, the ethyl acetate extracts of the leaves and stems were found to possess the most potent inhibitory effect against BChE, with IC50 values of 17.5 and 16.3 μg/mL, compared to physostigmine and galanthamine (IC50 values of 0.08 and 19.3 μM/mL, respectively).

3.5.5. Antimicrobial Activities

The leaves and stems of E. echinatus contain flavonoid compounds, which have been found to have considerable antimicrobial and antibacterial properties [61]. The antimicrobial test zone of inhibition was nearly identical to the positive control’s (0.1 mg/mL for gentamycin). This supports the effectiveness of the genus’s plant species in treating a number of infectious diseases.
The antibacterial properties of the essential oils and ethanolic extract of the tuber of E. kebericho, along with its fractions, were investigated. Its essential oils demonstrated efficacy against the most harmful Staphylococcus aureus, Enterococcus faecalis, and Klebsiella pneumoniae [88,109]. The essential oils of E. kebericho demonstrated efficacy against methicillin-resistant Staphylococcus aureus, with MIC values ranging from 78.125 to 625 μg/mL. The ethyl acetate fraction exhibited the strongest efficacy against methicillin-resistant Staphylococcus aureus, with an MIC value of 39.075 μg/mL. The extracts were potent against Enterococcus faecalis and Klebsiella pneumoniae, with MICs of 78.125 μg/mL and 1250 μg/mL, respectively.
The chloroform fraction of E.erinaceus Kit Tan extract exhibited the highest activity against S. Aureus, with an MIC value of 312.5 μg/mL, whereas E. fecalis exhibited the highest sensitivity to the hexane fraction, with an MIC value of 156.2 μg/mL.
The antimicrobial activity of the methanolic extract of the aerial parts of E. lanceolatus was also examined against eight bacterial strains. The extract showed weak to moderate antibacterial activity. The ethyl acetate fraction, on the other hand, showed the highest activity, followed by dichloromethane, n-hexane, and butanol fractions, with MIC values ranging from 256 to 1024 µg/mL [110].
Echinops ritro L. essential oils exhibited an antibacterial effect, and antibiofilm and bacterial membrane disruption have been proposed as mechanisms of action [111]. The antibacterial effect of extracts from the roots of Echinops ritro L. was due to the presence of thiophenes. Thiophenes had an antibacterial effect against S. aureus, with an MIC value of 8 µg/mL [112,113]. The antibacterial effects of thiophenes against E. coli have also been described, with MIC values of 64, 32, 64, 64 and 8 µg/mL [37]. Thiophenes isolated from the roots of Echinops ritro L. have been reported to have significant antifungal activity against various fungal isolates. The most active thiophenes were 5-(but-3-en-1-ynyl)-2,2-bithiophene (IC50 4.2 µM) against Colletotrichum gloeosporioides, α-terthiophene (IC50 1.9 µM), and 5-(3,4-dihydroxybut-1-ynyl)-2,2′-bithiophene (IC50 1.1 µM) against C. fragariae [25,29,114].
The antimicrobial activity of the methanolic extract of the flowering aerial parts of E. erinaceus was evaluated against six microorganisms: Bacillus subtilis, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, and Aspergillus niger. The authors found that the methanolic extract exhibited high antibacterial activity against all tested bacteria, especially against B. subtilis (27.5 ± 0.7 mm inhibition zone), and it also showed strong antifungal activity against C. albicans (26 ± 1.41 mm inhibition zone) compared to streptomycin [115]. The chloroform extract was active against B. subtilis (20.5 ± 1.41 mm), P. aeruginosa (17.5 ± 1.41 mm), and E. coli (18 ± 1.41 mm), but it had no activity against the fungal strains.

3.5.6. Insecticidal Properties

In Ethiopia, burning the dry roots of E. kebericho produces smoke that serves as a natural insect repellent, keeping mosquitoes away [116].
The roots of E. ellenbeckii and E. longisetus exhibit very strong anthelmintic activity. Findings from an earlier study [117] also suggested that the traditional uses of these two and most likely other Echinops spp. in the treatment of intestinal worm infestation had a scientific foundation.
A range of echinopsine derivatives with an acylhydrazone functional group that exhibit strong bactericidal, herbicidal, and insecticidal properties were synthesized by Cui et al. [118] (Figure 8).
The authors synthesized derivatives with benquinox [119], saijunmao [120], metaflumizone, and diflufenzopyr biological activities and echinopsine’s moiety. Cui et al. [118] found that the acylhydrazone derivatives have very good insecticidal potential against Lepidoptera pests, including fall armyworm (Spodoptera frugiperda), cotton bollworm (Helicoverpa armigera), corn borer (Ostrinia nubilalis), oriental armyworm (Mythimna separata), and diamondback moth (Plutella xylostella), compared to echinopsine. Echinops spp. also exhibited antimolluscicidal activity; thus, this plant is used to control snails that spread schistosomiasis in Ethiopia [121,122].

3.5.7. Anti-Malarial Activity

The methanolic extract of E. kebericho Mesfin’s rhizomes showed antiplasmodial efficacy against the rodent malaria parasite, P. berghei. This activity was attributed to the identified sesquiterpenes [123]. In a related investigation, various fractions of E. kebericho roots were shown to be active against Plasmodium berghei [124]. Bitew et al. concluded that the activity was due to the thiophenes in the E. hoehnelii root extract. Additional research is still needed to determine how well other species in the genus Echinops prevent malaria. Based on the currently available limited information, thiophene chemicals such as (18) and (19) are linked to the antimalarial activity of the genus Echinops (Figure 9); however, their mechanism of action remains to be elucidated.

3.5.8. Cytotoxicity

Flavonoids (apigenin), terpenes (macrochaetosides (A and B), cyclostenol, erinaceosin), and thiophenes (α-terthiophene) are among the anti-tumor secondary metabolites found naturally in the genus Echinops. Several studies have demonstrated the anticancer activity of various Echinops species against cancer cell lines. The most common activity is against colonic carcinoma, one of the most common and severe diseases, especially in industrialized countries. It is estimated that colorectal cancer affects 1.9 million people worldwide and kills approximately 900,000 annually [125]. Colorectal cancer makes up 3.47% of cancer cases in men and 3% in women [126,127]. Echinops species exhibit notable anticancer activity, as illustrated in Figure 10.
Antiproliferative properties of the methanolic extract and fractions of aerial parts of E. lanceolatus were evaluated against HepG2 (human liver cancer cell line), HeLa (cervical cancer cells), HT-29 (human colon cancer cell line), and A549 (adenocarcinomic human alveolar basal epithelial cells). The results demonstrated that the ethyl acetate fraction suppressed cancer cell proliferation in a dose-dependent manner at doses ranging from 0.82 to 200 µg/mL. The extract exhibited strong cytotoxicity against A549 (IC50 8.27 µg/mL) and moderate cytotoxicity against HeLa (IC50 28.27 µg/mL) [110].
E. latifolius Tausch., especially four thiophens isolated from its extract, namely 5-(3,4-dihydroxybut-1-ynyl)-2,2′-bithiophene, 5-(4-hydroxy-1-butynyl)-2,2′-bithiophene, 5-{4-[4-(5-pent-1,3-diynylthiophene-2-yl)-but-3-yny}-2,2′-bithiophene, and 5-(4-hydroxybut-1-one)-2,2′-bithiophene displayed cytotoxic activity (IC50 values of 5.2, 10.2, 3.1, and 6.5 µmol/L) against human malignant melanoma (A375-S2) and human cervical carcinoma (HeLa) cell lines [42].
The dichloromethane fraction of E. grijisi showed activity against HepG2 (IC50 = 2 µg/mL) due to the presence of 5-(4-isovaleroyloxybut-1-ynyl)-2,2′-bithiophene and 5-(3-acetoxy-4-isovaleroyloxybut-1-ynyl)-2,2′-bithiophene, while 5-(prop-1-ynyl)-2-(3,4-diacetoxybut-1-ynyl)-thiophene showed activity against myeloid leukemia HL-60 (IC50 = 8 µg/mL) [43]. Zhang et al. evaluated the cytotoxic effect of thiophenes isolated from E. grijisii on human acute myeloid leukemia (HL60) and human chronic myelogenous leukemia (K562) cell lines. Significant effects were observed for 5-(4-hydroxybut-1-ynyl)-2-(pent-1,3-diynyl)-thiophene (IC50 0.23 and 0.47 µg/mL, respectively) and 5-(penta-1,3-diynyl)-2-(3,4-dihydroxybut-1-ynyl)-thiophene (IC50 0.27 and 0.43 µg/mL, respectively) [30].
The methanolic extract from the underground part of E. giganteus also exhibited cytotoxic activity against prostate cancer (Mia PaCa2) and two leukemia cells (CCRF-CEM and CEM/ADR5000) with IC50 values of 9.84, 6.68, and 7.96 µg/mL, respectively [128].
E. macrochaetus extracts were found to be active against human breast cancer cell line MCF-7 (IC50 = 2.1 and 0.18 μM), HepG2 (IC50 = 2.9 and 3.3 μM), and HCT-116 (IC50 = 3.6 and 2.3 μM) due to the presence of macrochaetoside A and cyclostenol [63].

3.5.9. Food Supplement

The market must constantly expand and adapt to accommodate new food product sources and make the best use of existing resources due to the rising demand for food. Echinops sphaerocephalus, a plant that has long been used in beekeeping to provide bees with a consistent supply of nectar, may be one such resource. The oil content was recently examined to determine whether it would be appropriate for use as a culinary oil source. Its seeds, which are mainly composed of extremely important unsaturated linoleic fatty acids, have been found to contain up to 25% oil.
E. sphaerocephalus is considered a desirable culture for honey farms because of its high pollen and nectar content [19]. Its tube-shaped blooms readily draw pollinators to its aroma and yield 2–6 mg of honey apiece. In central and southern Europe, it is a common crop in honey production [94].
The term “mannas” refers to the sweet and sticky secretions that certain plants produce as a result of insect feeding, plant reactions to mechanical stimuli, or changes in the temperature outside of the plant tissues. The distribution of host and breeding insects, the period of production, and the manner of exploitation are some of the elements that contribute to the production of manna, even though the precise methods and conditions are still unknown. Several ecological and biological elements also contribute to the development and reproduction of manna-producing insects [13,129,130]. Mannas exhibit an array of general properties such as laxative, antipyretic, and cholagogue/choleretic effects [131,132,133]. Manna contains a large amount of cellulose (about 18%), and its syrup has been used in traditional medicine as a febrifuge and to treat severe coughs brought on by bronchial irritation [134]. Such findings highlight the multifaceted value of Echinops sphaerocephalus as a potential contributor to the food and pharmaceutical industries. Its diverse applications underscore the importance of further research aimed at optimizing its cultivation and sustainable utilization.

4. Conclusions

The genus Echinops represents a valuable source of structurally diverse secondary metabolites, particularly thiophenes, terpenes, flavonoids, and alkaloids, many of which are strongly correlated with its biological activities, such as antimalarial, anti-inflammatory, antidiabetic, cytotoxic, and neuroprotective effects. Current findings suggest that these compounds hold considerable promise for the development of novel therapeutic agents. However, the majority of studies remain at the in vitro or in vivo level, with limited clinical validation.
While preclinical studies support the use of Echinops species, further toxicological evaluations and clinical trials are essential to confirm efficacy and ensure the safe therapeutic applications of these species in modern medicine.

Author Contributions

Conceptualization, S.I., A.I., and S.N.; investigation, S.I., A.I., and M.T.; writing—original draft preparation, S.I., A.I., V.G., and M.T.; writing—review and editing, S.I., A.I., S.N., and V.G.; visualization, V.G., and S.I.; supervision, S.N.; project administration, S.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

This study is part of Scientific Project 466 No KP-06-H73/11 of the National Fund for Scientific Research in Bulgaria, National Program for Basic Research Projects—2023.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Garnatje, T.; Vallès, J.; Garcia, S.; Hidalgo, O.; Sanz, M.; Canela, M.Á.; Siljak-Yakovlev, S. Genome Size in Echinops L. and Related Genera (Asteraceae, Cardueae): Karyological, Ecological and Phylogenetic Implications. Biol. Cell 2004, 96, 117–124. [Google Scholar] [CrossRef]
  2. Garnatje, T.; Susanna, A.; Garcia-Jacas, N.; Vilatersana, R.; Vallès, J. A First Approach to the Molecular Phylogeny of the GenusEchinops (Asteraceae): Sectional Delimitation and Relationships with the GenusAcantholepis. Folia Geobot. 2005, 40, 407–419. [Google Scholar] [CrossRef]
  3. Sanchez-Jimenez, I.; Lazkov, G.; Hidalgo, O.; Garnatje, T. Molecular Systematics of Echinops L. (Asteraceae, Cynareae): A Phylogeny Based on ITS and TrnLtrnF Sequences with Emphasis on Sectional Delimitation. Taxon 2010, 59, 698–708. [Google Scholar] [CrossRef]
  4. Falah, F.; Shirani, K.; Vasiee, A.; Tabatabaee Yazdi, F.; Alizadeh Behbahani, B. In Vitro Screening of Phytochemicals, Antioxidant, Antimicrobial, and Cytotoxic Activity of Echinops Setifer Extract. Biocatal. Agric. Biotechnol. 2021, 35, 102102. [Google Scholar] [CrossRef]
  5. GBIF.org. GBIF Backbone Taxonomy: Echinops L. Available online: https://www.gbif.org/species/3109550 (accessed on 21 August 2025).
  6. Hedge, I.C. Vergleichende Chorologie Der Zentraleuropaischen Flora. Band III. Ed. H. Meusel & E.J. Jager. Edinb. J. Bot. 2010, 50, 247–248. [Google Scholar] [CrossRef]
  7. Kipp, L.R. The Flight Directionality of Honeybees Foraging on Real and Artificial Inflorescences. Can. J. Zool. 1987, 65, 587–593. [Google Scholar] [CrossRef]
  8. Rigó, A.; Malatinszky, Á.; Barina, Z. Inventory of the Urban Flora of Budapest (Hungary) Highlighting New and Noteworthy Floristic Records. Biodivers. Data J. 2023, 11, e110450. [Google Scholar] [CrossRef]
  9. Ginko, E.; Dobeš, C.; Saukel, J. Suitability of Root and Rhizome Anatomy for Taxonomic Classification and Reconstruction of Phylogenetic Relationships in the Tribes Cardueae and Cichorieae (Asteraceae). Sci. Pharm. 2016, 84, 585–602. [Google Scholar] [CrossRef]
  10. Skuhrovec, J.; Volovnik, S.; Gosik, R. Description of the Immature Stages of Larinus vulpes and Notes on Its Biology (Coleoptera, Curculionidae, Lixinae). ZooKeys 2017, 679, 107–137. [Google Scholar] [CrossRef]
  11. Řezáčová, V.; Řezáč, M.; Wilson, G.W.T.; Michalová, T. Arbuscular Mycorrhiza Can Be Disadvantageous for Weedy Annuals in Competition with Paired Perennial Plants. Sci. Rep. 2022, 12, 20703. [Google Scholar] [CrossRef]
  12. Greuter, W. Euro+Med PlantBase—The Information Resource for Euro-Mediterranean Plant Diversity. 2006. Available online: https://ww2.bgbm.org/EuroPlusMed/PTaxonDetail.asp?NameId=122540&PTRefFk=7000000 (accessed on 31 August 2025).
  13. Rameshk, M.; Khoshbin, E.; Moeinzadeh, M.; Sharififar, K.; Bahrami, D.; Sharififar, F. Mannas, Unique Products of a Dynamic Insect-Plant Interaction: Biodiversity, Conservation and Ethnopharmacological Considerations. Heliyon 2023, 9, e22976. [Google Scholar] [CrossRef]
  14. Tadesse, M. A Revision of the Genus Echinops (Compositae-Cardueae) in Tropical Africa. Kew Bull. 1997, 52, 879. [Google Scholar] [CrossRef]
  15. Friis, I.; Boulos, L. 2002. Flora of Egypt. Vol. 3. (Verbenaceae-Compositae). Nord. J. Bot. 2002, 22, 390. [Google Scholar] [CrossRef]
  16. Mozaffarian, V.; Ghahreman, A. Three New Species of Echinops (Compositae, Cynareae) from Iran. Bot. J. Linn. Soc. 2002, 140, 181–186. [Google Scholar] [CrossRef]
  17. Echinops ritro Subsp. Ruthenicus (Small Globe Thistle). Available online: https://www.gardenia.net/plant/echinops-ritro-subsp-ruthenicus (accessed on 5 July 2025).
  18. Patel, A.J.; Patel, N.M.; Patel, A.A.; Patel, J.; Patel, S. Comparative Analgesic Activity of Root and Aerial Part Methanolic Extracts of Echinops echinatus Roxb. Pharm. Lett. 2011, 3, 168–172. [Google Scholar]
  19. Raškauskas, P. Echinops Sphaerocephalus and Chrysochromulina Polylepis Algae Fractionation, Analysis and Evaluation. Master’s Thesis, Kauno Technologijos Universitetas, Kaunas, Lithuania, 2015. [Google Scholar]
  20. Bitew, H.; Hymete, A. The Genus Echinops: Phytochemistry and Biological Activities: A Review. Front. Pharmacol. 2019, 10, 1234. [Google Scholar] [CrossRef]
  21. Arroo, R.R.J.; Jacobs, J.J.M.R.; Van Gestel, J.A.M.; Kenkel, H.; Jannik, W.; Croes, A.F.; Wullems, G.J. Regulation of Thiophene Biosynthesis by Sulphate in Roots of Marigolds. New Phytol. 1997, 135, 175–181. [Google Scholar] [CrossRef]
  22. Shi, J.; Zhang, X.; Jiang, H. 2-(Penta-1,3-Diynyl)-5-(3,4-Dihydroxybut-1-Ynyl)Thiophene, a Novel NQO1 Inducing Agent from Echinops grijsii Hance. Molecules 2010, 15, 5273–5281. [Google Scholar] [CrossRef]
  23. Abegaz, B.M.; Tadesse, M.; Majinda, R. Distribution of Sesquiterpene Lactones and Polyacetylenic Thiophenes in Echinops. Biochem. Syst. Ecol. 2003, 19, 323–328. [Google Scholar] [CrossRef]
  24. Abegaz, B.M. Polyacetylenic Thiophenes and Terpenoids from the Roots of Echinops pappii. Phytochemistry 2001, 30, 879–881. [Google Scholar] [CrossRef]
  25. Fokialakis, N.; Cantrell, C.L.; Duke, S.O.; Skaltsounis, A.L.; Wedge, D.E. Antifungal Activity of Thiophenes from Echinops ritro. J. Agric. Food Chem. 2006, 54, 1651–1655. [Google Scholar] [CrossRef]
  26. Fokialakis, N.; Osbrink, W.L.; Mamonov, L.K.; Gemejieva, N.G.; Mims, A.B.; Skaltsounis, A.L.; Lax, A.R.; Cantrell, C.L. Antifeedant and Toxicity Effects of Thiophenes from Four Echinops Species against the Formosan Subterranean Termite, Coptotermes formosanus. Pest Manag. Sci. 2006, 62, 832–838. [Google Scholar] [CrossRef] [PubMed]
  27. Turgumbayeva, A. A Review on the Medicinal Plant Echinops ritro Species: Phytochemistry and Biological Activity. Farmacia 2023, 71, 455–462. [Google Scholar] [CrossRef]
  28. Chang, F.-P.; Chen, C.-C.; Huang, H.-C.; Wang, S.-Y.; Chen, J.-J.; Yang, C.-S.; Ou, C.-Y.; Wu, J.-B.; Huang, G.-J.; Kuo, Y.-H. A New Bithiophene from the Root of Echinops grijsii. Nat. Prod. Commun. 2015, 10, 2147–2149. [Google Scholar] [CrossRef] [PubMed]
  29. Zhang, X.; Ma, Z. Characterization of Bioactive Thiophenes from the Dichloromethane Extract of Echinops grijisii as Michael Addition Acceptors. Anal. Bioanal. Chem. 2010, 397, 1975–1984. [Google Scholar] [CrossRef]
  30. Zhang, P.; Liang, D.; Jin, W.; Qu, H.; Cheng, Y.; Li, X.; Ma, Z. Cytotoxic Thiophenes from the Root of Echinops grijisii Hance. Z. Naturforsch C. J. Biosci. 2009, 64, 193–196. [Google Scholar] [CrossRef]
  31. Sandjo, L.P.; Kuete, V.; Siwe, X.N.; Poumale, H.M.P.; Efferth, T. Cytotoxicity of an Unprecedented Brominated Oleanolide and a New Furoceramide from the Cameroonian Spice, Echinops giganteus. Nat. Prod. Res. 2016, 30, 2529–2537. [Google Scholar] [CrossRef]
  32. Kuete, V.; Sandjo, L.P.; Wiench, B.; Efferth, T. Cytotoxicity and Modes of Action of Four Cameroonian Dietary Spices Ethno-Medically Used to Treat Cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J. Ethnopharmacol. 2013, 149, 245–253. [Google Scholar] [CrossRef]
  33. Hymete, A.; Rohloff, J.; KjØsen, H.; Iversen, T. Acetylenic Thiophenes from the Roots of Echinops ellenbeckii from Ethiopia. Nat. Prod. Res. 2005, 19, 755–761. [Google Scholar] [CrossRef]
  34. Lam, J.; Christensen, L.P.; Thomasen, T. Thiophene Derivatives from Echinops Species. Phytochemistry 1991, 30, 1157–1159. [Google Scholar] [CrossRef]
  35. Liu, Y.; Ye, M.; Guo, H.-Z.; Zhao, Y.-Y.; Guo, D.-A. New Thiophenes from Echinops grijisii. J. Asian Nat. Prod. Res. 2002, 4, 175–178. [Google Scholar] [CrossRef]
  36. Liang, D.; Li, N.; Xiao, W.; Zhang, P.; Ma, Z.; Li, X. Chemical Constituents of the Root of Echinops grijisii Hance. Shenyang Yao Ke Da Xue Xue Bao 2008, 8, 007. [Google Scholar]
  37. Li, L.-B.; Xiao, G.-D.; Xiang, W.; Yang, X.; Cao, K.-X.; Huang, R.-S. Novel Substituted Thiophenes and Sulf-Polyacetylene Ester from Echinops ritro L. Molecules 2019, 24, 805. [Google Scholar] [CrossRef]
  38. Nakano, H.; Ali, A.; Ur Rehman, J.; Mamonov, L.K.; Cantrell, C.L.; Khan, I.A. Toxicity of Thiophenes from Echinops transiliensis (Asteraceae) against Aedes aegypti (Diptera: Culicidae) Larvae. Chem. Biodivers. 2014, 11, 1001–1009. [Google Scholar] [CrossRef]
  39. Bitew, H.; Mammo, W.; Hymete, A.; Yeshak, M. Antimalarial Activity of Acetylenic Thiophenes from Echinops Hoehnelii Schweinf. Molecules 2017, 22, 1965. [Google Scholar] [CrossRef]
  40. Nakano, H.; Cantrell, C.L.; Mamonov, L.K.; Osbrink, W.L.A.; Ross, S.A. Echinopsacetylenes a and B, New Thiophenes from Echinops transiliensis. Org. Lett. 2011, 13, 6228–6231. [Google Scholar] [CrossRef] [PubMed]
  41. Nakano, H.; Cantrell, C.L.; Mamonov, L.K.; Kustova, T.S.; Fronczek, F.R.; Ross, S.A. Chemical Constituents from Echinops nanus and Echinops transiliensis. Biochem. Syst. Ecol. 2012, 45, 127–129. [Google Scholar] [CrossRef]
  42. Wang, Y.; Li, X.; Li, L.-H.; Meng, D.-L.; Li, Z.-L.; Li, N. Two New Thiophenes from Echinops latifolius and Their Phototoxic Activities. Planta Med. 2007, 73, 696–698. [Google Scholar] [CrossRef] [PubMed]
  43. Jin, W.; Shi, Q.; Hong, C.; Cheng, Y.; Ma, Z.; Qu, H. Cytotoxic Properties of Thiophenes from Echinops grijissi Hance. Phytomedicine 2008, 15, 768–774. [Google Scholar] [CrossRef]
  44. Jin, Q.; Lee, J.W.; Jang, H.; Choi, J.E.; Kim, H.S.; Lee, D.; Hong, J.T.; Lee, M.K.; Hwang, B.Y. Dimeric Sesquiterpene and Thiophenes from the Roots of Echinops latifolius. Bioorg. Med. Chem. Lett. 2016, 26, 5995–5998. [Google Scholar] [CrossRef]
  45. Sun, N.; Wang, Y.; Ma, S.; Kang, H.; Zhou, C.; Jin, L.; Zhang, X.; Zhang, Y.; Yuan, Y.; Shu, P. A Review of the Phytochemistry and Biological Activities of Echinopsis radix. Molecules 2024, 29, 2267. [Google Scholar] [CrossRef]
  46. Wang, Y.; Li, X.; Meng, D.-L.; Li, Z.-L.; Zhang, P.; Xu, J. Thiophenes from Echinops latifolius. J. Asian Nat. Prod. Res. 2006, 8, 585–588. [Google Scholar] [CrossRef] [PubMed]
  47. Kiyekbayeva, L.; Mohamed, N.M.; Yerkebulan, O.; Mohamed, E.I.; Ubaidilla, D.; Nursulu, A.; Assem, M.; Srivedavyasasri, R.; Ross, S.A. Phytochemical Constituents and Antioxidant Activity of Echinops albicaulis. Nat. Prod. Res. 2017, 32, 1203–1207. [Google Scholar] [CrossRef] [PubMed]
  48. Wong, J.; Todd, M.; Rutledge, P. Recent Advances in Macrocyclic Fluorescent Probes for Ion Sensing. Molecules 2017, 22, 200. [Google Scholar] [CrossRef] [PubMed]
  49. Zhang, P.; Jin, W.-R.; Shi, Q.; He, H.; Ma, Z.-J.; Qu, H.-B. Two Novel Thiophenes from Echinops grijissi Hance. J. Asian Nat. Prod. Res. 2008, 10, 977–981. [Google Scholar] [CrossRef]
  50. Wu, Y.; Li, S.; Zhang, Z.; Sauriol, F.; Shi, Q.; Yang, J. New Thiophene Acetylene from Echinops spinosissimus subsp. spinosus. Chem. Nat. Comp. 2017, 53, 933–934. [Google Scholar] [CrossRef]
  51. Ibrahim, S.R.M.; Omar, A.M.; Bagalagel, A.A.; Diri, R.M.; Noor, A.O.; Almasri, D.M.; Mohamed, S.G.A.; Mohamed, G.A. Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and in Silico Evaluation of Their Potential as Cathepsin D Inhibitors. Plants 2022, 11, 539. [Google Scholar] [CrossRef]
  52. Neenu Krishna, P.U.; Muraleedharan, K. Alpha-Terthiophene and Its Functionalized Derivatives from Roots of Echinops grijisii to Produce Potential Organic Semiconductor Materials: A Theoretical Study. Mater. Today Commun. 2023, 36, 106453. [Google Scholar] [CrossRef]
  53. Zheleva-Dimitrova, D.; Simeonova, R.; Kondeva-Burdina, M.; Savov, Y.; Balabanova, V.; Zengin, G.; Petrova, A.; Gevrenova, R. Antioxidant and Hepatoprotective Potential of Echinops ritro L. Extracts on Induced Oxidative Stress in Vitro/in Vivo. Int. J. Mol. Sci. 2023, 24, 9999. [Google Scholar] [CrossRef]
  54. Zitouni-Nourine, S.H.; Belyagoubi-Benhammou, N.; El-Houaria Zitouni-Haouar, F.; Douahi, O.; Chenafi, F.; Fetati, H.; Chabane Sari, S.; Benmahieddine, A.; Zaoui, C.; Mekaouche, F.Z.N.; et al. Echinops spinosissimus Turra Root Methanolic Extract: Characterization of the Bioactive Components and Relative Wound Healing, Antimicrobial and Antioxidant Properties. Plants 2022, 11, 3440. [Google Scholar] [CrossRef]
  55. Chadwick, M.; Trewin, H.; Gawthrop, F.; Wagstaff, C. Sesquiterpenoids Lactones: Benefits to Plants and People. Int. J. Mol. Sci. 2013, 14, 12780–12805. [Google Scholar] [CrossRef]
  56. Chaudhuri, P.K. 7-Hydroxyechinozolinone, a New Alkaloid from the Flowers of Echinops echinatus. J. Nat. Prod. 1992, 55, 249–250. [Google Scholar] [CrossRef]
  57. Erenler, R.; Yilmaz, S.; Aksit, H.; Sen, O.; Demirtas, I. Antioxidant Activities of Chemical Constituents Isolated from Echinops orientalis Trauv. Rec. Nat. Prod. 2014, 8, 32–36. [Google Scholar]
  58. Radulović, N.S.; Denić, M.S. Essential Oils from the Roots of Echinops bannaticus Rochel ex Schrad. and Echinops sphaerocephalus L. (Asteraceae): Chemotaxonomic and Biosynthetic Aspects. Chem. Biodiv. 2013, 10, 658–676. [Google Scholar] [CrossRef] [PubMed]
  59. Dong, M.; Cong, B.; Yu, S.-H.; Sauriol, F.; Huo, C.-H.; Shi, Q.-W.; Gu, Y.-C.; Zamir, L.O.; Kiyota, H. Echinopines A and B: Sesquiterpenoids Possessing an Unprecedented Skeleton from Echinops spinosus. Org. Lett. 2008, 10, 701–704. [Google Scholar] [CrossRef] [PubMed]
  60. Li, L.; Ren, J.; Cheng, Z.; Zhu, H. Three New Sesquiterpenoids from Echinops ritro L. Helv. Chim. Acta 2010, 93, 1344–1349. [Google Scholar] [CrossRef]
  61. Hamdan, D.I.; Fayed, A.; Adel, R. Echinops taeckholmiana Amin: Optimization of a Tissue Culture Protocol, Biological Evaluation, and Chemical Profiling Using GC and LC-MS. ACS Omega 2021, 6, 13105–13115. [Google Scholar] [CrossRef]
  62. Sayed, K.A. A Pseudoguaiane Sesquiterpene Xylopyranoside from Echinops hussoni. Pharmazie 2001, 56, 415–417. [Google Scholar]
  63. Zamzami, T.A.; Abdallah, H.M.; Shehata, I.A.; Mohamed, G.A.; Alfaifi, M.Y.; Elbehairi, S.E.I.; Koshak, A.E.; Ibrahim, S.R.M. Macrochaetosides A and B, New Rare Sesquiterpene Glycosides from Echinops macrochaetus and Their Cytotoxic Activity. Phytochem. Lett. 2019, 30, 88–92. [Google Scholar] [CrossRef]
  64. Singh, R.P.; Singh, K.N.; Pande, V.B. Onstituents of Echinops niveus. Fitoterapia 1990, 61, 279–281. [Google Scholar]
  65. Tene, M.; Tane, P.; Sondengam, B.L.; Connolly, J.D. Lignans from the Roots of Echinops giganteus. Phytochemistry 2004, 65, 2101–2105. [Google Scholar] [CrossRef]
  66. Senejoux, F.; Demougeot, C.; Karimov, U.; Muyard, F.; Kerram, P.; Aisa, H.A.; Girard-Thernier, C. Chemical Constituents from Echinops integrifolius. Biochem. Syst. Ecol. 2012, 47, 42–44. [Google Scholar] [CrossRef]
  67. Patel, A. Isolation and Characterization of Lupeol from Echinops echinatus Roxb. Root. Eur. J. Pharm. Med. Res. 2016, 3, 385–387. [Google Scholar]
  68. Singh, B.; Gambhir, S.S.; Pandey, V.B.; Joshi, V.K. Anti-Inflammatory Activity of Echinops echinatus. J. Ethnopharmacol. 1989, 25, 189–199. [Google Scholar] [CrossRef]
  69. Tsafantakis, N.; Zelianeos, K.; Termentzi, A.; Vontzalidou, A.; Aligiannis, N.; Fokialakis, N. Triterpenes from Echinops spinosissimus Turra subsp. spinosissimus. Phytochem. Lett. 2019, 30, 273–277. [Google Scholar] [CrossRef]
  70. He, L.; Chao, Q.; Li, R.; Lin, G.; Huang, H. A New Pentacyclic Triterpene, Gmeliniin A, from Echinops gmelinii Turcz. Chin. J. Chem. 2000, 18, 112–114. [Google Scholar] [CrossRef]
  71. Abdallah, H.M.; Ezzat, S.M.; El Dine, R.S.; Abdel-Sattar, E.; Abdel-Naim, A.B. Protective Effect of Echinops Galalensis against CCl4-Induced Injury on the Human Hepatoma Cell Line (Huh7). Phytochem. Lett. 2012, 6, 73–78. [Google Scholar] [CrossRef]
  72. Diab, K.A.; Fahmy, M.A.; Hassan, E.E.; Nagy, A.M.; Farghaly, A.A.; Hassan, E.M.; Omara, E.A. Safety Evaluation of Ethanolic Extract from Aerial Flowering Part of Spiny Globe Thistle (Echinops spinosus) in Mice: Phytochemical Screening and Genotoxicity. MRGTEM 2025, 902, 503854. [Google Scholar] [CrossRef] [PubMed]
  73. Singh, R.P.; Pandey, V.B. Nivetin, a Neoflavonoid from Echinops niveus. Phytochemistry 2001, 29, 680–681. [Google Scholar] [CrossRef]
  74. Singh, S.; Upadhyay, R.K.; Pandey, M.B.; Singh, J.P.; Pandey, V.B. Flavonoids from Echinops echinatus. J. Asian Nat. Prod. Res. 2006, 8, 197–200. [Google Scholar] [CrossRef]
  75. Panero, J.L.; Funk, V.A. The Value of Sampling Anomalous Taxa in Phylogenetic Studies: Major Clades of the Asteraceae Revealed. Mol. Phylogenet. Evol. 2008, 47, 757–782. [Google Scholar] [CrossRef]
  76. Ram, S.N.; Roy, R.; Singh, B.; Singh, R.P.; Pandey, V.B. An Acylflavone Glucoside of Echinops echinatus Flowers. Planta Med. 1996, 62, 187. [Google Scholar] [CrossRef]
  77. Boumaraf, M.; Benyahia, S.; Mekkiou, R.; Benayache, S.; Benayache, F. Flavonoids from Ethyl Acetate Extract of Echinops spinosus (Asteraceae). Der Pharma Chem. 2016, 8, 158–160. [Google Scholar]
  78. Kumar, P.; Ahamad, T.; Mishra, D.P.; Khan, M.F. Plant Neoflavonoids: Chemical Structures and Biological Functions. In Plant-derived Bioactives; Springer: Berlin/Heidelberg, Germany, 2020; pp. 35–57. [Google Scholar] [CrossRef]
  79. Čižmárová, B.; Hubková, B.; Tomečková, V.; Birková, A. Flavonoids as Promising Natural Compounds in the Prevention and Treatment of Selected Skin Diseases. Int. J. Mol. Sci. 2023, 24, 6324. [Google Scholar] [CrossRef] [PubMed]
  80. Zengin, G.; Fahmy, N.M.; Sinan, K.I.; Uba, A.I.; Bouyahya, A.; Lorenzo, J.M.; Yıldıztugay, E.; Eldahshan, O.A.; Fayez, S. Differential Metabolomic Fingerprinting of the Crude Extracts of Three Asteraceae Species with Assessment of Their in Vitro Antioxidant and Enzyme-Inhibitory Activities Supported by in Silico Investigations. Processes 2022, 10, 1911. [Google Scholar] [CrossRef]
  81. Mahmood, A.A.R.; Khadeem, E.J. Phytochemical Investigation of Flavonoids Glycoside in the Ira-Qi Echinops Heterophyl-Lus (Compositae). Pharm. Glob 2013, 4, 1–8. [Google Scholar]
  82. Yadava, R.N.; Singh, S.K. New Anti-Inflammatory Active Flavanone Glycoside from the Echinops echinatus Roxb. Indian J. Chem. 2006, 45, 1004–1008. [Google Scholar]
  83. Balabanova, V.; Zheleva-Dimitrova, D.; Voynikov, Y.; Zengin, G.; Joubert, O.; Gevrenova, R. New Insight into Enzyme Inhibitory and Anti-Proliferative Activity of Echinops ritro L. (Asteraceae). C. R. Acad. Bulg. Sci. 2023, 76, 1893–1902. [Google Scholar] [CrossRef]
  84. Padashetty, S.A.; Mishra, S.H. An HPTLC Method for the Evaluation of Two Medicinal Plants Commercially Available in the Indian Market under the Common Trade Name Brahmadandi. Chromatographia 2007, 66, 447–449. [Google Scholar] [CrossRef]
  85. Videla, L.A. Oxidative Stress Signaling Underlying Liver Disease and Hepatoprotective Mechanisms. World J. Hepatol. 2009, 1, 72–78. [Google Scholar] [CrossRef]
  86. Li, S.; Tan, H.-Y.; Wang, N.; Zhang, Z.-J.; Lao, L.; Wong, C.-W.; Feng, Y. The Role of Oxidative Stress and Antioxidants in Liver Diseases. Int. J. Mol. Sci. 2015, 16, 26087–26124. [Google Scholar] [CrossRef] [PubMed]
  87. Li, R.; Xia, Y.; Gao, Z.; Song, Y.; Guo, Z.; Yang, Y. Transcriptome Analysis to Reveal the Mechanism of the Effect of Echinops latifolius Polysaccharide B on Palmitate-Induced Insulin-Resistant. Biomed. Pharmacother. 2021, 143, 112203. [Google Scholar] [CrossRef] [PubMed]
  88. Rafay, M. Phytochemicals Analysis and Antimicrobial Activities of Echinops echinatus from Cholistan Desert, Pakistan. Agrobiol. Rec. 2021, 5, 21–27. [Google Scholar] [CrossRef] [PubMed]
  89. Wang, J.; Dong, X.; Ma, F.; Li, C.; Bu, R.; Lu, J.; Gao, J.; Xue, P. Metabolomics Profiling Reveals Echinops latifolius Tausch Improves the Trabecular Micro-Architecture of Ovariectomized Rats Mainly via Intervening Amino Acids and Glycerophospholipids Metabolism. J. Ethnopharmacol. 2020, 260, 113018. [Google Scholar] [CrossRef]
  90. Kamel, N.N.; Aly, H.F.; Fouad, G.I.; Abd El-Karim, S.S.; Anwar, M.M.; Syam, Y.M.; Elseginy, S.A.; Ahmed, K.A.; Booles, H.F.; Shalaby, M.B.; et al. Anti-Alzheimer Activity of New Coumarin-Based Derivatives Targeting Acetylcholinesterase Inhibition. RSC Adv. 2023, 13, 18496–18510. [Google Scholar] [CrossRef]
  91. Younis, I.Y.; Mohsen, E.; Ibrahim, R.M.; Fernie, A.R.; Alseekh, S.; Salem, M.A. Non-Targeted Metabolomics and Chemometrics for Saffron (Crocus sativus L.) Authentication and Adulteration Detection in Relation to Its Anticholinesterase Activity. Food Chem. Adv. 2023, 2, 100217. [Google Scholar] [CrossRef]
  92. Jamila, N.; Khan, N.; Hwang, I.M.; Khan, S.N. Elemental Analysis and Bioactivities of Echinops echinatus Roxb. (Globe Thistle) via Spectroscopic Techniques. Pak. J. Bot. 2019, 52, 121–128. [Google Scholar] [CrossRef]
  93. Karamać, M.; Kosińska, A.; Estrella, I.; Hernández, T.; Dueñas, M. Antioxidant Activity of Phenolic Compounds Identified in Sunflower Seeds. Eur. Food Res. Technol. 2012, 235, 221–230. [Google Scholar] [CrossRef]
  94. Horn, G.; Kupfer, A.; Kalbitz, J.; Gerdelbracht, H.-J.; Kluge, H.; Eder, K.; Dräger, B. Great Globe Thistle Fruit (Echinops sphaerocephalus L.), a Potential New Oil Crop. Eur. J. Lipid Sci. Technol. 2008, 110, 662–667. [Google Scholar] [CrossRef]
  95. Brunetti, C.; Di Ferdinando, M.; Fini, A.; Pollastri, S.; Tattini, M. Flavonoids as Antioxidants and Developmental Regulators: Relative Significance in Plants and Humans. Int. J. Mol. Sci. 2013, 14, 3540–3555. [Google Scholar] [CrossRef]
  96. Deavall, D.G.; Martin, E.A.; Horner, J.M.; Roberts, R. Drug-Induced Oxidative Stress and Toxicity. J. Toxicol. 2012, 2012, 645460. [Google Scholar] [CrossRef]
  97. Kwon, Y.K.; Choi, S.J.; Kim, C.R.; Kim, J.K.; Kim, Y.-J.; Choi, J.H.; Song, S.; Kim, C.; Park, G.G.; Park, C.-S.; et al. Antioxidant and Cognitive-Enhancing Activities of Arctium lappa L. Roots in Aβ1-42-Induced Mouse Model. Appl. Biol. Chem. 2016, 59, 553–565. [Google Scholar] [CrossRef]
  98. Rojas-González, A.; Figueroa-Hernández, C.Y.; González-Rios, O.; Suárez-Quiroz, M.L.; González-Amaro, R.M.; Hernández-Estrada, Z.J.; Rayas-Duarte, P. Coffee Chlorogenic Acids Incorporation for Bioactivity Enhancement of Foods: A Review. Molecules 2022, 27, 3400. [Google Scholar] [CrossRef]
  99. Bouba A, A. Phenolic Compounds and Radical Scavenging Potential of Twenty Cameroonian Spices. Agric. Biol. J. N. Am. 2010, 1, 213–224. [Google Scholar] [CrossRef]
  100. Vivó-Barrachina, L.; Rojas-Chacón, M.J.; Navarro-Salazar, R.; Belda-Sanchis, V.; Pérez-Murillo, J.; Peiró-Puig, A.; Herran-González, M.; Pérez-Bermejo, M. The Role of Natural Products on Diabetes Mellitus Treatment: A Systematic Review of Randomized Controlled Trials. Pharmaceutics 2022, 14, 101. [Google Scholar] [CrossRef]
  101. Othman, M.S.; Khaled, A.M.; Al-Bagawi, A.H.; Fareid, M.A.; Hameed, R.A.; Zahra, F.A.A.; Moneim, A.E.A. Echinops Spinosus Effect against Diabetes and Its Hepatorenal Complications: Total Extract and Flavonoids Fraction. Environ. Sci. Pollut. Res. Int. 2022, 29, 38606–38617. [Google Scholar] [CrossRef] [PubMed]
  102. Alam, S.; Sarker, M.M.R.; Sultana, T.N.; Chowdhury, M.N.R.; Rashid, M.A.; Chaity, N.I.; Zhao, C.; Xiao, J.; Hafez, E.E.; Khan, S.A.; et al. Antidiabetic Phytochemicals from Medicinal Plants: Prospective Candidates for New Drug Discovery and Development. Front. Endocrinol. 2022, 13, 800714. [Google Scholar] [CrossRef] [PubMed]
  103. Fatima, S.; Afroz, S.; Qureshi, A.S. Anti-Diabetic Activity of Hydro-Alcoholic Root Extract of Echinops echinatus and Its Beneficial Effects on Nephropathy in Experimental Rats. Indian J. Res. Pharm. Biotechnol. 2017, 5, 19–27. [Google Scholar]
  104. Sarvaiya, D.D.; Sheth, N.R.; Dudhrejiya, A.V. Antidiabetic and Antioxidant Activity of Roots of Echinops echinatus Roxb. Pharmacologyonline 2017, 2, 10–39. [Google Scholar]
  105. Chaudhry, S.R.Y.; Akram, A.; Aslam, N.; Wajid, M.; Iqbal, Z.; Nazir, I.; Jabeen, Q.; Muhammad, S. Antidiabetic and Antidyslipidemic Potential of Echinops echinatus in Rat Models of Type I and Type II Diabetes. Pak. J. Pharm. Sci. 2019, 32, 505–514. [Google Scholar]
  106. Benrahou, K.; Doudach, L.; Mrabti, H.N.; El Guourrami, O.; Zengin, G.; Bouyahya, A.; Cherrah, Y. Acute Toxicity, Phenol Content, Antioxidant and Postprandial Anti-Diabetic Activity of Echinops spinosus Extracts. Int. J. Second. Metab. 2022, 9, 91–102. [Google Scholar] [CrossRef]
  107. Heidari, H.; Azizi, Y.; Maleki-Ravasan, N.; Tahghighi, A.; Khalaj, A.; Pourhamzeh, M. Nature׳s Gifts to Medicine: The Metabolic Effects of Extracts from Cocoons of Larinus hedenborgi (Coleoptera: Curculionidae) and Their Host Plant Echinops cephalotes (Asteraceae) in Diabetic Rats. J. Ethnopharmacol. 2021, 284, 114762. [Google Scholar] [CrossRef]
  108. Liu, Y.; Wang, X.; Chang, H.; Gao, X.; Dong, C.; Li, Z.; Hao, J.; Wang, J.; Fan, Q. Mongolian Medicine Echinops Prevented Postmenopausal Osteoporosis and Induced ER/AKT/ERK Pathway in BMSCs. Biosci. Trends 2018, 12, 275–281. [Google Scholar] [CrossRef]
  109. Deyno, S.; Mtewa, A.G.; Hope, D.; Bazira, J.; Makonnen, E.; Alele, P.E. Antibacterial Activities of Echinops kebericho Mesfin Tuber Extracts and Isolation of the Most Active Compound, Dehydrocostus Lactone. Front. Pharmacol. 2021, 11, 608672. [Google Scholar] [CrossRef] [PubMed]
  110. Seukep, A.J.; Zhang, Y.-L.; Xu, Y.-B.; Guo, M.-Q. In Vitro Antibacterial and Antiproliferative Potential of Echinops lanceolatus Mattf. (Asteraceae) and Identification of Potential Bioactive Compounds. Pharmaceuticals 2020, 13, 59. [Google Scholar] [CrossRef] [PubMed]
  111. Ameya, G.; Gure, A.; Dessalegn, E. Antimicrobial Activity of Echinops kebericho against Human Pathogenic Bacteria and Fungi. Afr. J. Tradit. Complement. Altern. Med. 2016, 13, 199–203. [Google Scholar] [CrossRef] [PubMed]
  112. Jiang, B.; Wang, F.; Liu, L.; Tian, S.; Li, W.; Yang, X.; Wu, Y.; Huang, Y.; Yi, J.; Yu, C.; et al. Antibacterial Activity and Action Mechanism of the Echinops ritro L. Essential Oil against Foodborne Pathogenic Bacteria. J. Essent. Oil Bear. Plants 2017, 20, 1172–1183. [Google Scholar] [CrossRef]
  113. Othman, L.; Sleiman, A.; Abdel-Massih, R.M. Antimicrobial Activity of Polyphenols and Alkaloids in Middle Eastern Plants. Front. Microbiol. 2019, 10, 911. [Google Scholar] [CrossRef]
  114. Xu, D.G.; Lv, W.; Dai, C.Y.; Zhu, F.F.; Xu, G.H.; Ma, Z.J.; Chen, Z. 2-(Pro-1-Ynyl)-5-(5,6-Dihydroxypenta-1,3-Diynyl) Thiophene Induces Apoptosis through Reactive Oxygen Species-Mediated JNK Activation in Human Colon Cancer SW620 Cells. Anat. Rec. 2015, 298, 376–385. [Google Scholar] [CrossRef]
  115. Sweilam, S.H.; Abdel, M.; Foudah, A.I.; Alqarni, M.H.; Elattal, N.A.; El-Gindi, O.D.; El-Sherei, M.M.; Abdel-Sattar, E. Phytochemical, Antimicrobial, Antioxidant, and in Vitro Cytotoxicity Evaluation of Echinops erinaceus Kit Tan. Separations 2022, 9, 447. [Google Scholar] [CrossRef]
  116. Jemberie, W.; Tadie, A.; Enyew, A.; Debebe, A.; Raja, N. Repellent Activity of Plant Essential Oil Extracts against Malaria Vector Anopheles arabiensis Patton (Diptera: Culicidae). Entomon 2016, 41, 91–98. [Google Scholar] [CrossRef]
  117. Hymete, A.; Iversen, T.-H.; Rohloff, J.; Erko, B. Screening of Echinops ellenbeckii and Echinops longisetus for Biological Activities and Chemical Constituents. Phytomedicine 2005, 12, 675–679. [Google Scholar] [CrossRef]
  118. Cui, P.; Cai, M.; Meng, Y.; Yang, Y.; Song, H.; Liu, Y.; Wang, Q. Design, Synthesis and Biological Activities of Echinopsine Derivatives Containing Acylhydrazone Moiety. Sci. Rep. 2022, 12, 2935. [Google Scholar] [CrossRef] [PubMed]
  119. Hamadache, M.; Benkortbi, O.; Hanini, S.; Amrane, A.; Khaouane, L.; Si-Moussa, C. A Quantitative Structure Activity Relationship for Acute Oral Toxicity of Pesticides on Rats: Validation, Domain of Application and Prediction. J. Hazard. Mater. 2016, 303, 28–40. [Google Scholar] [CrossRef] [PubMed]
  120. Keshavarz, M.H.; Pouretedal, H.R. Simple and Reliable Prediction of Toxicological Activities of Benzoic Acid Derivatives without Using Any Experimental Data or Computer Codes. Med. Chem. Res. 2012, 22, 1238–1257. [Google Scholar] [CrossRef]
  121. Carter, R.C. Phytolacca Dodecandra Berries as a Means of Controlling Bilharzia Transmitting Snails. By Lugt Ch. B. Amsterdam: Royal Tropical Institute (1986), Bulletin 812, pp. 61, Guilders 10.00. Exp. Agric. 1988, 24, 490–491. [Google Scholar] [CrossRef]
  122. Lambert, J.D.H.; Temmink, J.H.M.; Marquis, J.; Parkhurst, R.M.; Lugt, C.B.; Lemmich, E.; Wolde-Yohannes, L.; de Savigny, D. Endod: Safety Evaluation of a Plant Molluscicide. Regulat. Toxicol. Pharmacol. 1991, 14, 189–201. [Google Scholar] [CrossRef]
  123. Biruksew, A.; Zeynudin, A.; Alemu, Y.; Golassa, L.; Yohannes, M.; Debella, A.; Urge, G.; Spiegeleer, B.D.; Suleman, S. Zingiber Officinale Roscoe and Echinops kebericho Mesfin Showed Antiplasmodial Activities against Plasmodium Berghei in a Dosedependent Manner in Ethiopia. Ethiop. J. Health Sci. 2018, 28, 655–664. [Google Scholar] [CrossRef]
  124. Chaudhuri, P.K. Echinozolinone, an Alkaloid from Echinops echinatus. Phytochemistry 2001, 26, 587–589. [Google Scholar] [CrossRef]
  125. Morgan, E.; Arnold, M.; Gini, A.; Lorenzoni, V.; Cabasag, C.J.; Laversanne, M.; Vignat, J.; Ferlay, J.; Murphy, N.; Bray, F. Global Burden of Colorectal Cancer in 2020 and 2040: Incidence and Mortality Estimates from GLOBOCAN. Gut 2022, 72, 338–344. [Google Scholar] [CrossRef]
  126. Khalil Mohamed, A.; Mohamed, E.; Mohamed, A. Evaluation of Anticancer Activities of Ulva Lactuca Ethanolic Extract on Colorectal Cancer Cells. Egypt. J. Chem. 2023, 66, 531–539. [Google Scholar] [CrossRef]
  127. Brenner, D.R.; Heer, E.; Sutherland, R.L.; Ruan, Y.; Tinmouth, J.; Heitman, S.J.; Hilsden, R.J. National Trends in Colorectal Cancer Incidence among Older and Younger Adults in Canada. JAMA Netw. Open 2019, 2, e198090. [Google Scholar] [CrossRef] [PubMed]
  128. Kuete, V.; Krusche, B.; Youns, M.; Voukeng, I.; Fankam, A.G.; Tankeo, S.; Lacmata, S.; Efferth, T. Cytotoxicity of Some Cameroonian Spices and Selected Medicinal Plant Extracts. J. Ethnopharmacol. 2011, 134, 803–812. [Google Scholar] [CrossRef] [PubMed]
  129. Mohammadi, M.; Dini, M. Identification of Manna Sources, Production Mechanism and Utilization in Iran. Iran. J. Med. Aromat. Plants Res. 2003, 17, 75–109. [Google Scholar]
  130. Li, W.; Li, Y. Managing Rangeland as a Complex System: How Government Interventions Decouple Social Systems from Ecological Systems. Ecol. Soc. 2012, 17, 9. [Google Scholar] [CrossRef]
  131. Azadbakht, M.; Pishva, H.; Mohammadi; Alinejad, F. Effect of Manna from Cotoneaster Discolor on Infant Jaundice (Effect on Blood Bilirubin Level). J. Med. Plants 2005, 4, 36–44. [Google Scholar]
  132. Azadbakht, M.; Dehkordi, N.G.; Sadjadi, S.E.; Ghannadi, A.; Taleb, M. Iranian Herbal Pharmacopoeia. Depart. Med. Sci. 2003, 6, 63–69. [Google Scholar]
  133. Takavar, S.; Mohamadi, M. Producer’s Factors and Mechanisms of Manna in Iran. J. Med. Plants 2008, 7, 28–37. [Google Scholar]
  134. Nasirzadeh, A.A.R.; Javidtash, I.; Riasat, M. Identification of Echinops Species and Study on Some Biological Characteristics of Larinus Vulpes Oliv. As Manna Producer in Fars Province. Iran. J. Med. Aromat. Plants Res. 2005, 21, 335–346. [Google Scholar] [CrossRef]
Figure 1. Global distribution map of Echinops L. Reproduced from GBIF.org (accessed on 21 August 2025), under the terms of the Creative Commons Attribution 4.0 License [5].
Figure 1. Global distribution map of Echinops L. Reproduced from GBIF.org (accessed on 21 August 2025), under the terms of the Creative Commons Attribution 4.0 License [5].
Pharmaceuticals 18 01353 g001
Figure 2. PRISMA flowchart illustrating the literature review’s identification, screening, eligibility, and inclusion process. Created with Canva (www.canva.com).
Figure 2. PRISMA flowchart illustrating the literature review’s identification, screening, eligibility, and inclusion process. Created with Canva (www.canva.com).
Pharmaceuticals 18 01353 g002
Figure 3. Alkaloids present in Echinops.
Figure 3. Alkaloids present in Echinops.
Pharmaceuticals 18 01353 g003
Figure 4. Summary of reported biological activities of various Echinops spp., based on the available literature. Created with Canva (www.canva.com).
Figure 4. Summary of reported biological activities of various Echinops spp., based on the available literature. Created with Canva (www.canva.com).
Pharmaceuticals 18 01353 g004
Figure 5. Antidiabetic mechanisms and phytochemical effects of selected Echinops species in experimental models of type 2 diabetes. Created with Canva (www.canva.com).
Figure 5. Antidiabetic mechanisms and phytochemical effects of selected Echinops species in experimental models of type 2 diabetes. Created with Canva (www.canva.com).
Pharmaceuticals 18 01353 g005
Figure 6. Echinops latifolius improved bone microstructure in ovariectomized rats by modulating amino acid and glycerophospholipid metabolism. Created with Canva (www.canva.com).
Figure 6. Echinops latifolius improved bone microstructure in ovariectomized rats by modulating amino acid and glycerophospholipid metabolism. Created with Canva (www.canva.com).
Pharmaceuticals 18 01353 g006
Figure 7. Anti-Alzheimer’s potential of Echinops species via cholinesterase inhibition. Created with Canva (www.canva.com).
Figure 7. Anti-Alzheimer’s potential of Echinops species via cholinesterase inhibition. Created with Canva (www.canva.com).
Pharmaceuticals 18 01353 g007
Figure 8. Biological activities of echinopsine derivatives.
Figure 8. Biological activities of echinopsine derivatives.
Pharmaceuticals 18 01353 g008aPharmaceuticals 18 01353 g008b
Figure 9. Thiophenes with antimalarial activity.
Figure 9. Thiophenes with antimalarial activity.
Pharmaceuticals 18 01353 g009
Figure 10. Anticancer potential of Echinops species and isolated bioactive compounds against human cancer cell lines. Created with Canva (www.canva.com).
Figure 10. Anticancer potential of Echinops species and isolated bioactive compounds against human cancer cell lines. Created with Canva (www.canva.com).
Pharmaceuticals 18 01353 g010
Table 1. Structures of thiophenes present in Echinops L.
Table 1. Structures of thiophenes present in Echinops L.
Name of the Secondary MetaboliteChemical StructureIsolated fromReference
monothiophenes
2-(Penta-1,3-diynyl)-5-(3,4-dihydroxybut-1-ynyl)thiophenePharmaceuticals 18 01353 i001E. grijsii Hance[22]
5-(penta-1,3-diynyl)-2-(3-chloro-4-hydoxy-but-1-ynyl)-thiophenePharmaceuticals 18 01353 i002E. ellenbeckii[23]
E. giganteus[20]
E. hispidus Fresen.[20]
E. longisetus[20]
E. macrochaetus[20]
2-(pent-3-en-1-ynyl)-5-(4-hydroxybut-1-ynyl)-thiophenePharmaceuticals 18 01353 i003E. pappii[24]
5-(4-hydroxybut-1-ynyl)-2-(pent-1,3-diynyl)-thiophenePharmaceuticals 18 01353 i004E. pappii[24]
E. ritro[25,26,27]
E. grijsii[28,29,30]
E. giganteus[20,31,32]
5-(penta-1,3-diynyl)-2-(but-3-en-1-ynyl)-thiophenePharmaceuticals 18 01353 i005E. ellenbeckii[33]
E. exaltatus Schrad[34]
E. humilis Bieb.[34]
E. niveus Walb. ex Royle[34]
E. orientalis Trautv.[34]
E. sphaerocephalus L.[34]
E. dahuricus Fisch.[34]
E. latijolius Tausch.[34]
E. leiopolyceras Bomm.[34]
E. microcephalus Sibth. et Sm.[34]
E. ruthenicus’[34]
E. spinosissimus Turra[34]
E. spinosus L.[34]
E. tschimganicus B. Fedtsch.[34]
E. exaltatus Schrad[34]
E. gmelini Turcz[34]
5-(penta-1,3-diynyl)-2-(4-acetoxy-but-1-ynyl)-thiophenePharmaceuticals 18 01353 i006E. ellenbeckii[33]
E. humilis Bieb.[34]
E. niveus Walb. ex Royle[34]
E. orientalis Trautv.[34]
E. sphaerocephalus L.[34]
E. dahuricus Fisch.[34]
E. latijolius Tausch.[34]
E. leiopolyceras Bomm.[34]
E. microcephalus Sibth. et Sm.[34]
E. ruthenicus’[34]
E. spinosissimus Turra[34]
E. spinosus L.[34]
E. tschimganicus B. Fedtsch.[34]
E. humilis Bieb.[34]
E. commutatus Juratzka[34]
E. gmelini Turcz.[34]
E. exaltatus Schrad[34]
5-(5,6-dihydroxy-hexa-1,3-diynyl)-2-(prop-1-ynyl)-thiophene (echinoynethiophene A)Pharmaceuticals 18 01353 i007E. grijsii[35,36]
E. grijsii[30]
5-(penta-1,3-diynyl)-2-(3,4-dihydroxybut-1-ynyl)-thiophenePharmaceuticals 18 01353 i008E. grijsii[28,35,36]
E. ritro[37]
E. grijsii[22,29]
E. grijsii[30]
E. giganteus[31]
E. transiliensis[38]
E. hoehnelii[39]
Echinopsacetylenes BPharmaceuticals 18 01353 i009E. transiliensis[40]
Echinothiophenegenol
((R)-5-hydroxy-6-((1E,3E)-6-hydroxyhexa-1,3-dien-1-yl)-2-(hydroxymethyl)thieno[2,3-e]isobenzofuran-8(6H)-one)
Pharmaceuticals 18 01353 i010E. grijsii[30]
E. nanus[41]
5-(4-acetoxy-3-chlorobut-1-ynyl)-2-(pent-1,3-diynyl)-thiophenePharmaceuticals 18 01353 i011E. ritro[25]
E. exaltatus Schrad[34]
E. humilis Bieb.[34]
E. niveus Walb. ex Royle[34]
E. orientalis Trautv.[34]
E. sphaerocephalus L.[34]
E. tschimganicus B. Fedtsch.[34]
E. exaltatus Schrad[34]
E. gmelini Turcz[34]
5-(prop-1-ynyl)- 2-(3,4-diacetoxybut-1-ynyl)-thiophenePharmaceuticals 18 01353 i012E. latifolius[42]
E. grijsii[43]
5-(1,2-dihydroxy-ethyl)-2-(Z)-hept-5-ene-1,3-diynylthiophenePharmaceuticals 18 01353 i013E. latifolius[44]
5-(1,2-dihydroxyethyl)-2-(E)-hept-5-ene-1,3-diynylthiophenePharmaceuticals 18 01353 i014E. latifolius[44]
5-(penta-1,3-diynyl)-2-(3-methoxy-4-hydroxy-but-1-ynyl)-thiophenePharmaceuticals 18 01353 i015E. hoehnelii[39]
5-(penta-1,3-diynyl)-2-(3-methoxy-4-acetoxy-but-1-ynyl)-thiophenePharmaceuticals 18 01353 i016E. hoehnelii[39]
2-(penta-1, 3-diynyl)-5-(3, 4-dihydroxybut-1-ynyl) thiophenePharmaceuticals 18 01353 i017 [22,45]
5-(penta-1,3-diynyl)-2-(3-acetoxy-4-hydroxy-but-1-ynyl)-thiophenePharmaceuticals 18 01353 i018E. transiliensis[38]
Junipic acid
(5-(prop-1-yn-1-yl)thiophene-2-carboxylic acid)
Pharmaceuticals 18 01353 i019E. ritro[37]
dithiophenes
5-(but-3-en-1-ynyl)-2,2′-bithiophene (1)Pharmaceuticals 18 01353 i020E. macrochaetus[23]
E. exaltatus Schrad [34]
E. humilis Bieb.[34]
E. niveus Walb. ex Royle [34]
E. orientalis Trautv. [34]
E. sphaerocephalus L.[34]
E. dahuricus Fisch.[34]
E. latijolius Tausch.[34,46]
E. leiopolyceras Bomm.[34]
E. microcephalus Sibth. et Sm.[34]
E. ruthenicus’[34]
E. spinosissimus Turra[26,34]
E. spinosus L.[34]
E. tschimganicus B. Fedtsch.[34]
E. exaltatus Schrad [34]
E. gmelini Turcz[34]
E. pappii Chiov.[23]
E. ritro[25,27]
E. grijsii[28]
E. nanus Bunge[41]
E. albicaulis[26,47]
5-[(5-acetoxymethyl-2-thienyl)-2-(but-3-en-1-ynyl)]-thiophenePharmaceuticals 18 01353 i021E. ellenbeckii[33]
5-(3,4-dihydroxybut-1-ynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i022E. grijsii[28,29,30,35,36]
E. ritro[37]
E. latifolius[42]
E. transiliensis[38]
2,2′-bithiophene-5-carboxylic acidPharmaceuticals 18 01353 i023E. grijsii[28,35]
E. ritro[37]
5-(3-buten-1-ynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i024E. grijsii[35]
5-(4-isovaleroyloxybut-1-ynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i025E. grijsii[28,35]
E. grijsii[46]
E. grijsii[43]
E. grijsii[48]
E. ritro[25,26]
Grijisone APharmaceuticals 18 01353 i026E. grijsii[49]
5-(4-hydroxy-3-methoxy-1-butyny)-2,2′-bithiophene
(4-([2,2′-bithiophen]-5-yl)-2-methoxybut-3-yn-1-ol)
Pharmaceuticals 18 01353 i027E. grijsii[28]
1-([2,2′-bithiophen]-5-yl)ethan-1-onePharmaceuticals 18 01353 i028E. latifolius[42]
E. grijsii[28]
E. ritro[37]
5-formyl-2,2′-bithiophenePharmaceuticals 18 01353 i029E. grijsii[28]
5′-(3,4-Dihydroxybut-1-yn-1-yl)-[2,2′-bithiophene]-5-carbaldehydePharmaceuticals 18 01353 i030E. ritro[37]
4-Hydroxy-1-(5′-methyl-[2,2′-bithiophen]-5-yl)butan-1-onePharmaceuticals 18 01353 i031E. ritro[37]
5′-(3,4-Dihydroxybut-1-yn-1-yl)-[2,2′-bithiophene]-5-carboxylic acidPharmaceuticals 18 01353 i032E. ritro[37]
Methyl 2,2′-bithiophene-5-carboxylatePharmaceuticals 18 01353 i033E. grijsii[28]
5-(3-hydroxymethyl-3-isovaleroyloxyprop-1-ynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i034E. latifolius[46]
E. grijsii[28]
5-(4-hydroxy-1-butynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i035E. latifolius[42]
E. ritro[25]
E. latifolius[42]
E. grijsii[28,30]
E. ritro[37]
E. ritro[26]
5-(4-acetoxy-1-butynl)-2,2′-bithiophene
(4-([2,2′-bithiophen]-5-yl)but-3-yn-1-yl acetate)
Pharmaceuticals 18 01353 i036E. grijsii[28]
5-(3-hydroxy-4-isovaleroyloxybut-1-ynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i037E. latifolius[46]
5-(3-acetoxy-4-isovaleroyloxybut-1-ynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i038E. latifolius[46]
5-(3,4-diacetoxybut-1-ynyl)-2,2′-bithiophenePharmaceuticals 18 01353 i039E. ritro[25,26]
E. latifolius[34]
E. niveus Walb. ex Royle [34]
E. orientalis Trautv. [34]
E. gmelini Turcz.[34]
E. giganteum[34]
E. sphaerocephalus L. [34]
E. dahuricus Fisch. [34]
E. ruthenicus[34]
E. commutatus Juratzka [34]
E. spinosus L. [34]
E. tschimganicus B. Fedtsch.[34]
E. exaltatus Schrad [34]
E. gmelini Turcz[34]
E. grijsii[43]
E. grijsii[29]
E. grijsii[43]
E. transiliensis[38]
5-(4-hydroxybut-1-one)-2,2′-bithiophene
(1-([2,2′-bithiophen]-5-yl)-4-hydroxybutan-1-one)
Pharmaceuticals 18 01353 i040E. latifolius[42]
E. ritro[37]
Methoxy-arctinol-b (2-methoxy-2-(3′-methoxy-5′-(prop-1-yn-1-yl)-[2,2′-bithiophen]-5-yl)ethan-1-ol)Pharmaceuticals 18 01353 i041E. latifolius[44]
Arctinol-b
(1-(5′-(prop-1-yn-1-yl)-[2,2′-bithiophen]-5-yl)ethane-1,2-diol)
Pharmaceuticals 18 01353 i042E. grijsii[30,37]
E. latifolius[44]
E. ritro[37]
Arctinol a
((5′-(prop-1-yn-1-yl)-[2,2′-bithiophen]-5-yl)methanol)
Pharmaceuticals 18 01353 i043E. latifolius[37,44]
E. ritro[37]
E. ritro[37]
Methyl [5′-(1-propynyf)-2,2′-bithienyl-5-yl] carboxylatePharmaceuticals 18 01353 i044E. latifolius[44]
5-(3-hydroxy-4-acetoxybut-1-ynyl)-2,2′-bithiophene
(4-([2,2′-bithiophen]-5-yl)-2-hydroxybut-3-yn-1-yl acetate)
Pharmaceuticals 18 01353 i045E. transiliensis[38]
E. transiliensis[38]
5′-(3,4-dihydroxybut-1-yn-1-yl)-[2,2′-bithiophene]-5-carbaldehydePharmaceuticals 18 01353 i046E. ritro[37]
5′-(3,4-dihydroxybut-1-yn-1-yl)-[2,2′-bithiophene]-5-carboxylic acidPharmaceuticals 18 01353 i047E. ritro[37]
4-hydroxy-1-(5′-methyl-[2,2′-bithiophen]-5-yl)butan-1-onePharmaceuticals 18 01353 i048E. ritro[37]
Arctinal
(5′-(prop-1-yn-1-yl)-[2,2′-bithiophene]-5-carbaldehyde)
Pharmaceuticals 18 01353 i049E. ritro[37]
4-(5′-methyl-[2,2′-bithiophen]-5-yl)but-3-yn-1-olPharmaceuticals 18 01353 i050E. ritro[37]
Arctic acidPharmaceuticals 18 01353 i051E. ritro[37]
2,2-Dimethyl-4-[5-(prop-1-ynyl)-2,2-bithiophen-5-yl]-1,3-dioxolanePharmaceuticals 18 01353 i052E. spinosus[50]
terthiophenes
α-terthiophene (2)Pharmaceuticals 18 01353 i053E. ellenbeckii[23]
E. pappii[23]
E. niveus Walb. ex Royle [34]
E. orientalis Trautv. [34]
E. gmelini Turcz. [34]
E. giganteum[34]
E. sphaerocephalus L. [34]
E. dahuricus Fisch. [34]
E. ruthenicus[34]
E. commutatus Juratzka [34]
E. spinosus L. [34]
E. tschimganicus B. Fedtsch. [34]
E. exaltatus Schrad [34]
E. gmelini Turcz [34]
E. macrochaetus[23]
E. grijsii[28,48,51,52]
E. latifolius[34,46]
E. ritro[25,53]
E. ritro[26]
E. nanus[41]
E. albicaulis[25,26,47]
E. transiliensis[41]
Echinops spinosissimus Turra [34,54]
5-chloro- α-terthiophenePharmaceuticals 18 01353 i054E. grijsii[35,52]
5-acetyl α-terthiophenePharmaceuticals 18 01353 i055E. grijsii[35,52]
5,5′-dichloro-α-terthiophenePharmaceuticals 18 01353 i056E. grijsii[35,52]
Grijisyne APharmaceuticals 18 01353 i057E. grijsii[49]
5-{4-[4-(5-pent-1,3-diynylthiophen-2-yl)-but-3-ynyloxy]-but-ynyl}-2,2′-bithiophenePharmaceuticals 18 01353 i058E. latifolius[42]
CardopatinePharmaceuticals 18 01353 i059E. grijsii[28,35,45]
E. latifolius[45,46]
E. ritro[25,26]
IsocardopatinePharmaceuticals 18 01353 i060E. grijsii[28,29,35,43]
E. ritro[25]
Echinopsacetylenes APharmaceuticals 18 01353 i061E. transiliensis[40]
Table 2. Structures of the main terpenes found in Echinops spp.
Table 2. Structures of the main terpenes found in Echinops spp.
Name of the TerpeneChemical StructureIsolated fromReference
Dehydrocostus lactonePharmaceuticals 18 01353 i062E. amplexicauli[23]
E. kebericho[23]
CostunolidePharmaceuticals 18 01353 i063E. amplexicaulis,[23,24]
E. kebericho,[23,24]
E. pappii[23,24]
DihydrocostunolidePharmaceuticals 18 01353 i064E. amplexicaulis[23]
Echinopines APharmaceuticals 18 01353 i065E. spinosus[59]
Echinopines BPharmaceuticals 18 01353 i066E. spinosus[59]
(3α,4α,6α)-3,13-dihydroxyguaia-7(11),10(14)-dieno-12,6-lactone)Pharmaceuticals 18 01353 i067E. ritro[60]
β-vatirenenePharmaceuticals 18 01353 i068E. taeckholmiana[61]
jatamol APharmaceuticals 18 01353 i069E. taeckholmiana[61]
(3α,4α,6α,11ß)-3-hydroxyguai-1(10)-eno-12,6-lactone)Pharmaceuticals 18 01353 i070E. ritro[60]
(11α)-11,13-dihydroarglanilic acid methyl esterPharmaceuticals 18 01353 i071E. ritro[60]
VulgarinPharmaceuticals 18 01353 i072E. ritro[60]
(3R,3aS,6aR,9S,9aR,9bS)-octahydro-3,9-dimethyl-6-methyleneazuleno[4,5-b]furan2,8(3H,9bH)-d ionePharmaceuticals 18 01353 i073E. ritro[60]
(3aS,6aR,8S,9S,9aR,9bR)-decahydro-8-hydroxy-9-methyl-3,6 dimethyleneazuleno[4,5-b]furan-2(9bH)-onePharmaceuticals 18 01353 i074E. ritro[60]
(3aS,6aR,8R,9R,9aR,9bR)-decahydro-8-hydroxy-3,3,9-trimethyl-6-methyleneazuleno[4,5-b]furan-2(9bH)-onePharmaceuticals 18 01353 i075E. ritro[60]
(3R,3aS,6aR,8S,9S,9aR,9bS)-decahydro-8-hydroxy-3,9-dimethyl-6-methyleneazuleno[4,5-b]furan-2(9bH)-onePharmaceuticals 18 01353 i076E. ritro[60]
SantamarinPharmaceuticals 18 01353 i077E. pappii[24]
E. ritro[60]
ReynosinPharmaceuticals 18 01353 i078E. pappii[24]
Caryophyllene epoxidePharmaceuticals 18 01353 i079E. giganteus[23]
E. hispidus[23]
EchusosidePharmaceuticals 18 01353 i080E. hussoni Boiss.[62]
(3S,3aS,5aR,6R,8R,9bS)-decahydro-6,8-dihydroxy-3,5a-dimethyl-9-methylenenaphtho[1,2-b]furan-2(9bH)-onePharmaceuticals 18 01353 i081E. ritro[60]
(3S,3aS,5aR,6S,9bS)-3,3a,4,5,5a,6-hexahydro-6-hydroxy-3,5a,9-trimethylnaphtho[1,2-b]furan-2,7(9aH,9bH)-dionePharmaceuticals 18 01353 i082E. ritro[60]
2,6,10-trimethyldodeca-2,6,10-trienePharmaceuticals 18 01353 i083E. albicaulis[47]
Macrochaetosides APharmaceuticals 18 01353 i084E. macrochaetus[63]
Macrochaetosides BPharmaceuticals 18 01353 i085E. macrochaetus[63]
Latifolanone APharmaceuticals 18 01353 i086E. latifolius[44]
Atractylenolide-IIPharmaceuticals 18 01353 i087E. latifolius[44]
ß-amyrinPharmaceuticals 18 01353 i088E. niveus[64]
Betulinic acidPharmaceuticals 18 01353 i089E. niveus[64]
LupeolPharmaceuticals 18 01353 i090E. niveus[64]
E. giganteus[65]
E. integrifolius[66]
E. echinatus[67]
TaraxasterolPharmaceuticals 18 01353 i091E. niveus[64]
Taraxasterol acetatePharmaceuticals 18 01353 i092E. niveus[64]
E. echinatus[68]
20-oxo-30-nortaraxast-21-en-3β-olPharmaceuticals 18 01353 i093Echinops latifolius Tausch [69]
Taraxeryl acetatePharmaceuticals 18 01353 i094E. taeckholmiana[61]
ß-sitosterolPharmaceuticals 18 01353 i095E. niveus[64]
E. transiliensis[41]
E. giganteus[32]
E. orientalis[57]
ß-sitosterol glucosidePharmaceuticals 18 01353 i096E. niveus[64]
E. giganteus[65]
E. integrifolius[66]
E. albicaulis[47]
ReynosinPharmaceuticals 18 01353 i097E. pappii[24]
Gmeliniin APharmaceuticals 18 01353 i098E. gmelinii[70]
StigmasterolPharmaceuticals 18 01353 i099E. transiliensis[41]
E. macrochaetus[63]
E. integrifolius[66]
E. giganteus[32]
Lupeol acetatePharmaceuticals 18 01353 i100E. integrifolius[66]
E. echinatus[67]
E. albicaulis[47]
Lupeol linoleatePharmaceuticals 18 01353 i101E. albicaulis[47]
Ajugasterone CPharmaceuticals 18 01353 i102E. grijisii[36]
Ursolic acidPharmaceuticals 18 01353 i103E. giganteus[32]
Echinopsolide A (3ß-acetoxy-15α-bromoolean-13ß,28-olide)Pharmaceuticals 18 01353 i104E. giganteus[31]
ß-amyrin acetatePharmaceuticals 18 01353 i105E. giganteus[31]
3ß-acetoxy-taraxast-12,20(30)-diene-11α-21α-diolPharmaceuticals 18 01353 i106E. galalensis[71]
α-amyrinPharmaceuticals 18 01353 i107E. galalensis[71]
ErythrodiolPharmaceuticals 18 01353 i108E. galalensis[71]
Lup-20(29)-ene-1,3-diolPharmaceuticals 18 01353 i109E. galalensis[63]
CyclostenolPharmaceuticals 18 01353 i110E. macrochaetus[63]
Table 3. Flavonoids in Echinops spp.
Table 3. Flavonoids in Echinops spp.
Flavonoids and Other Phenolic CompoundsChemical StructureIsolated fromReference
ApigeninPharmaceuticals 18 01353 i111E. niveus[64]
E. echinatus[76]
E. integrifolius[66]
E. spinosus[77]
E. albicaulis[47]
LuteolinPharmaceuticals 18 01353 i112E. niveus[64]
E. grijisii[36]
Nivegin
(5,7-dihydroxy-4-(4-hydroxyphenyl)-2H-chromen-2-one)
Pharmaceuticals 18 01353 i113E. niveus[64,78]
Nivetin
(5,7-dihydroxy-4-(4-methoxyphenyl)-2H-chromen-2-one)
Pharmaceuticals 18 01353 i114E. niveus[73,79]
Apigenin 7-O-glucosidePharmaceuticals 18 01353 i115E. echinatus[76]
E. spinosus[77]
E. orientalis[57]
E. ritro[80]
EchitinPharmaceuticals 18 01353 i116E. echinatus[76]
EchinosidePharmaceuticals 18 01353 i117E. echinatus[74]
7-hydroxyisoflavonePharmaceuticals 18 01353 i118E. echinatus[74]
KaempferolPharmaceuticals 18 01353 i119E. echinatus[74]
Kaempferol-4′-methyletherPharmaceuticals 18 01353 i120E. echinatus[74]
Kaempferol-7-methyletherPharmaceuticals 18 01353 i121E. echinatus[74]
Kaempferol-3-O-α-L-rhamnosidePharmaceuticals 18 01353 i122E. echinatus[74]
E. heterophyllus[81]
Myrecetin-3-O-α-L-rhamnosidePharmaceuticals 18 01353 i123E. echinatus[74]
ChrysoeriolPharmaceuticals 18 01353 i124E. integrifolius[66]
HispidulinPharmaceuticals 18 01353 i125E. integrifolius[66]
JaceidinPharmaceuticals 18 01353 i126E. integrifolius[66]
CentaureidinPharmaceuticals 18 01353 i127E. integrifolius[66]
AxillarinPharmaceuticals 18 01353 i128E. integrifolius[66]
GenkwaninPharmaceuticals 18 01353 i129E. albicaulis[47]
Apigenin-7-O-(6″-trans-pcoumaroyl- ß -D-glucopyranosidePharmaceuticals 18 01353 i130E. orientalis[57]
E. spinosus[77]
5,7-dihydroxy-8,4′-dimethoxyflavanone-5-O-α-L-rhamno-pyranosyl-7-O-ß-D-arabinopyranosyl (1→4)-O-ß-D-glucopyranoside E. echinatus[82]
CandidonePharmaceuticals 18 01353 i131E. giganteus[32]
Chlorogenic acidPharmaceuticals 18 01353 i132E. grijisii[36]
CynarinPharmaceuticals 18 01353 i133E. grijisii[36]
RutinPharmaceuticals 18 01353 i134E. heterophyllus[81]
E. albicaulis[47]
(+)-4-(3-methylbutanoyl)-2,6-di(3,4-dimethoxy)phenyl-3,7-dioxabicyclo[3.3.0]octanePharmaceuticals 18 01353 i135E. giganteus[65]
(+)-4-hydroxy-2,6- di(3,4-dimethoxy)phenyl-3,7-dioxabicyclo[3.3.0]octanePharmaceuticals 18 01353 i136E. giganteus[65]
E. giganteus[31]
E. giganteus[32]
Jaceidin
(5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6-dimethoxychromen-4-one)
Pharmaceuticals 18 01353 i137E. integrifolius[66]
centaureidin
(5,7,3′-Trihydroxy-3,6,4′-trimethoxyflavone)
Pharmaceuticals 18 01353 i138E. integrifolius[66]
Hispidulin
(4′,5,7-Trihydroxy-6-methoxyflavone)
Pharmaceuticals 18 01353 i139E. integrifolius[66]
axillarin Pharmaceuticals 18 01353 i140E. integrifolius[66]
Hexacosyl-(E)-ferulatePharmaceuticals 18 01353 i141E. nanus[41]
UmbelliferonePharmaceuticals 18 01353 i142E. integrifolius[66]
SyringinPharmaceuticals 18 01353 i143E. grijisii[36]
1,5-dicaffeoylquinic acidPharmaceuticals 18 01353 i144E. galalensis[71]
E. ritro[83]
3,5-dicaffeoylquinic acid
(isochlorogenic acid A)
Pharmaceuticals 18 01353 i145E. ritro[83]
3,4-dicaffeoylquinic acid
(isochlorogenic acid C)
Pharmaceuticals 18 01353 i146E. ritro[53]
4,5-dicaffeoylquinic acidPharmaceuticals 18 01353 i147E. ritro[53]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ivanova, S.; Ivanova, A.; Todorova, M.; Gledacheva, V.; Nikolova, S. Echinops as a Source of Bioactive Compounds—A Systematic Review. Pharmaceuticals 2025, 18, 1353. https://doi.org/10.3390/ph18091353

AMA Style

Ivanova S, Ivanova A, Todorova M, Gledacheva V, Nikolova S. Echinops as a Source of Bioactive Compounds—A Systematic Review. Pharmaceuticals. 2025; 18(9):1353. https://doi.org/10.3390/ph18091353

Chicago/Turabian Style

Ivanova, Simona, Alexandra Ivanova, Mina Todorova, Vera Gledacheva, and Stoyanka Nikolova. 2025. "Echinops as a Source of Bioactive Compounds—A Systematic Review" Pharmaceuticals 18, no. 9: 1353. https://doi.org/10.3390/ph18091353

APA Style

Ivanova, S., Ivanova, A., Todorova, M., Gledacheva, V., & Nikolova, S. (2025). Echinops as a Source of Bioactive Compounds—A Systematic Review. Pharmaceuticals, 18(9), 1353. https://doi.org/10.3390/ph18091353

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop